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INTRODUCTION 
1. Herpes Simplex Virus 1 
1.1 Epidemiology 
Herpes Simplex Virus Type 1 (HSV-1) is a common existing virus that is known 
to cause infection in the majority of the world’s population [1,2,3]. HSV-1 can establish 
latency with the potential to cause recurrent disease in the host for a lifetime [4]. In the 
United States, 50% of the total population has been estimated to be seropositive for 
HSV-1, while in Asia and Europe reported a higher incidence of HSV-1 infection, as 
high as 80% [5,6,7]. The reports of HSV-1 infection across the world explicitly 
demonstrates its ubiquitous prevalence. Approximately, 20,000 new cases appear 
annually with an increased risk in children and aged individuals (45-49yr old) [5,8].  
HSV-1 primarily infects the orofacial region causing skin lesions (cold sores) 
[9,2]. During latency, HSV-1 harbors in the trigeminal ganglion and acquires a quiescent 
latency mode in the absence of infectious virions [10]. Reactivation of HSV-1 can lead 
to ocular infections causing blindness [11,12]. Herpes Stromal Keratitis (HSK) is the 
leading cause of corneal blindness in the United States [11]. Corneal epithelial defect 
and stromal inflammation cause corneal blindness, that obscures the clear vision during 
the pathogenesis of HSK [13]. Contemporary therapeutics such as anti-viral (acyclovir) 
and anti-inflammatory (corticosteroid) drugs have been shown to control the disease 
transiently but cannot subdue the HSK disease severity. Therefore, an urgent need for a 
promising cure is crucial to treat HSK causing corneal blindness.  
 
2 
 
 
 
1.2. HSV-1 Structure and Lytic Life Cycle  
HSV-1 is a double-stranded DNA virus encapsulated within an icosahedral 
nucleocapsid consisting of 162 capsomeres [14,15]. The HSV-1 viral genome encodes 
84 proteins that play a major role in the lytic life cycle of the virus. The first step of the 
lytic cycle is the entry of the HSV-1 virus into the host cell which is initiated by the 
attachment and fusion of the virus to the host cell surface proteins (heparan sulfates). 
There are several glycoproteins namely, gB, gC, gD, gH, and gL that are involved in its 
interaction with the host cell surface receptors [16]. Nectin-1, herpes virus entry 
mediator (HVEM), and paired immunoglobulin-like type 2 receptor-alpha (PILR-α) 
receptor on the corneal epithelium has been reported to be the key receptors which help 
in the HSV-1 viral entry [17,18]. Furthermore, upon the entry of the virus into the host 
cell, the transcription machinery for viral DNA replication and assembly of new viral 
capsids will occur following the insertion of the viral genome into the host nucleus [19]. 
Consequently, the host cell machinery will aid in the expression of immediate early (IE), 
early (E), and the late (L) proteins required for the synthesis of new virions [20,21]. 
Finally, a newly synthesized DNA will be packaged into a nucleocapsid to form a 
complete virion [22].  
An interesting aspect of the HSV-1 life cycle is its establishment of latency in the 
trigeminal ganglion. Once the active viral replication subsides, the viral genome remains 
in the infected host cell, thereby maintaining the virus in the latent phase [23,24]. The 
expression of latency associated transcripts promotes the HSV-1 latency [25]. There are 
ongoing studies to understand further the factors associated with the establishment and 
maintenance of HSV-1 latency in the trigeminal ganglion.  However, reports have 
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suggested that stress can induce a shift from latent to the lytic cycle (active replication) 
of the HSV-1 virus which can lead to catastrophic conditions in the host. Notably, In the 
mouse model of HSK, the disease is not induced by the virus reactivation, since the 
cornea is the primary site of infection that favors being a good model to study the 
pathology of the disease similar as in humans.  
1.3. Pathogenesis of Herpes Stromal Keratitis 
1.3.1. Pre-clinical Phase 
Development of HSK in the mouse models is very similar to the events that take 
place in the human eyes. However, in mouse model primary HSV-1 infection is 
conducted by directly infecting the cornea. While in human eyes the majority of HSV-1 
infection occurs via reactivation of the virus, termed as the recurrent infection. 
Pathogenesis of HSK can be broadly categorized into the pre-clinical and the clinical 
phase (Figure 1). The preclinical phase lasts through 7 days post-infection, after which 
the clinical phase of HSK will commence which is responsible for the development of 
corneal pathology (Figure 1). 
In the pre-clinical phase of the HSK disease, the active replication of the virus is 
controlled by the innate immune response [26,27]. This response is induced by the 
influx of early innate immune cells such as neutrophils, macrophages and dendritic cells 
for the initial attempt to clear the virus [28]. The innate immune cells can secrete 
mediators such as tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), nitric oxide and 
other reactive oxygen species that can aid in virus clearance but, can subsequently 
damage the corneal tissue causing detrimental effects [29]. A plethora of pro-
inflammatory factors is released by the innate immune cells such as Interleukins (IL-1, 
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IL-6, IL-8, IL-12) and macrophage inflammatory proteins (MIP-1α) [30]. Neutrophils are 
the short-lived cells that survive 2-3 days post HSV-1 infection in cornea [31]. 
Neutrophils play an essential role in viral clearance via phagocytosis of the virus and by 
the release reactive oxygen species (ROS). Meanwhile, the antigen presenting cells 
pick up these phagocytosed viral particles to elicit the T-cell responses. Consequently, 
this promotes the onset of the clinical phase in the HSK pathogenesis.  
1.3.1. Clinical Phase 
In mouse models of HSV-1 infection, the clinical phase will commence after 8-9 
days post infection. During this phase, characteristic features of HSK pathogenesis will 
appear in the infected cornea, such as the development of hem-angiogenesis, and 
corneal opacity which leads to corneal damage and blindness. T-cells have been 
reported to be the major cell types responsible for the HSK disease severity. 
Interestingly, studies have demonstrated that the lack of T-cells will not promote the 
development of HSK disease [32,33]. CD4+ T cells play a predominant role in secreting 
pro-inflammatory factors and chemotactic signals to help the extravasation of the 
polymorphonuclear cells (PMNs) [30,34].  
Of note, the influx of neutrophils occurs during the clinical phase, causing a 
biphasic response during HSK disease progression [35,36]. Apart from the T-cells, the 
second wave of neutrophils influx is also responsible for the HSK disease severity. 
Surprisingly, the infiltrated neutrophils in the second wave are resistant to apoptosis 
[31]. Eventually, the existence of neutrophils for an extended period in the infected 
cornea will cause increased corneal tissue damage [37,38]. To moderate this immuno-
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inflammatory condition, there are anti-inflammatory molecules and neuropeptides 
produced from the corneal sensory nerve stimulation) [39,40,41] 
2. Cornea 
2.1. Structure of normal cornea and tear film 
The cornea is a unique avascular and a transparent tissue that not only protects 
the anterior ocular surface but also aids in clear vision. Normally the corneal surface 
maintains its moist and smooth refractive surface in the presence of trilaminar tear film 
with a thickness of about 4-6μm. It is composed of lipid, aqueous and mucin layers [42], 
(Figure 3). Tear film also plays a role in supplying the cornea with nutrients and 
protecting the ocular surface from invading pathogens [43,44]. Tear film (Figure 3) 
consists of the outer lipid (oil) layer produced from meibomian glands (modified 
sebaceous glands) located in the tarsal plates [45]. Meibum consists primarily of 
phospholipids and maintains its fluidic property, due to its low melting temperature. It 
acts like a surfactant that spreads over the aqueous layer of tear film [46]. Hence, the 
absence of a meibomian layer results in evaporation of tear film [47]. The middle 
aqueous layer of tear film comprises 90% of the tear film and consists of water, 
electrolytes, and proteins [48]. It is produced mostly from lacrimal glands that contain 
soluble mucins which contribute to the viscosity of the tear film. The middle aqueous 
layer functions in not only providing lubrication, protecting from foreign materials but 
also in delivering nutrients such as oxygen, glucose, and proteins to the underlying 
corneal tissue [49].The innermost mucus layer is secreted by the conjunctival goblet 
cells, in addition to corneal and conjunctival epithelium [50]. This layer consists of ocular 
mucus composed of primarily the mucins that protect, lubricate and anchor aqueous 
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tear film to the underlying corneal epithelium. Mucins are high molecular weight 
glycoproteins located on the apical surface of the epithelium [51]. There are two classes 
of mucins, which includes a secretory and membrane-bound form [52]. The secretary 
form of mucin further consists of two forms, the large gel-forming mucin and the small 
soluble mucin [44,53,54]. MUC5AC is one of the major large gel-forming mucin 
expressed in conjunctival goblet cells. The secreted forms of mucins lack a 
transmembrane domain which is produced by the goblet cells [55]. In contrast, the 
membrane-bound mucins have a short cytoplasmic tail with a single transmembrane 
domain and a glycosylated extracellular domain. The corneal and conjunctival epithelial 
cells contain membrane-bound mucins namely, MUC1, MUC4, and MUC16 that 
functions to form glycocalyx at the epithelial cell-tear film interface [56]. The glycocalyx 
protects corneal epithelium from shear forces or desiccation [57]. The corneal and 
conjunctival epithelium is covered by microvilli, microplicae, and glycocalyx composed 
of glycoproteins and glycolipids [50,58,59]. The glycocalyx extends between microplicae 
and microvilli through branching and associates itself to the epithelial cell membrane 
and also assists in binding to the mucus layer [60]. Hence, the mucus layer binds to the 
glycocalyx and moves freely across the cornea without firmly attaching itself to the 
corneal epithelium [61]. Glycocalyx helps in even spreading of the mucus across the 
corneal epithelium. However, deficiency in tear film production or increased tear 
evaporation causes dry eye conditions leads to corneal epithelial damage [52]. 
Structurally cornea is comprised of five morphologically distinct layers (Fig 2) that 
includes (a) corneal epithelium (b) Bowman’s layer, (c) stroma, (d) Descemet’s 
membrane and the (e) endothelium. The three major functional layers include the 
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anterior corneal epithelium, middle tough collagenous stroma and the posterior 
monolayer of the endothelium [62]. 
Corneal epithelium (Figure 2) is 50-70μm thick and is derived from the surface 
ectoderm during embryogenesis [63]. Corneal epithelium consists of 5-6 layers of 
nucleated cells, which can be further subdivided into three layers, (i) surface cell layer 
(ii) wing like cell layer (iii) Basal layer. The apical (surface) layer is a 2-3 layer with 
stratified squamous non keratinized epithelium that exhibits surface 
microvilli/microplicae that contacts with the ocular mucins [63,64]. It is also a protective 
layer, as it continuously shed cells. The middle wing-like the cell layer is 1-2 layers with 
polyhedral shaped cells. The deeper basal cell layer is the germinative layer of the 
corneal epithelium which consists of columnar cells. The corneal epithelium is devoid of 
goblet cells and is continuous with the conjunctival epithelium at the limbus [65,66]. 
Corneal epithelial cells are actively metabolizing cells with abundant mitochondria 
present in the wing like cells but scarce in the basal layer, while the wing like cells and 
the surface cells contain rich glycogen deposits [64] Junctional complexes, such as tight 
junction proteins (Zonula occludens-1, occludens, claudin-1) desmosomes, and 
intermediate filaments play a major role in maintaining corneal epithelial cell integrity 
and polarity [66]. Epithelial cells express intermediate filament proteins with their diverse 
expression depending on the location and differentiation pattern [67]. These filaments 
are formed by the pairing of type-1 (acidic) and type-II molecules (basic/neutral) in a 1:1 
ratio. Cytokeratins function in maintaining epithelial integrity, mechanical stability and 
regulating intracellular pathways such as wound healing/apoptosis [67,68]. Stability of 
epithelial cells is maintained by cytokeratins through their interaction with the 
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desmosomes and the hemidesmosomes between the epithelial cells and to the 
basement membrane. Since the expression pattern of cytokeratin sheds light on the 
differentiation pattern of the epithelium,  it is used as a potent epithelial differentiation 
marker, as well as a diagnostic tumor marker [67,69]. Corneal epithelial cells express 
K3 (type II)/K12 (type I) pair in all layers of the epithelium, and the suprabasal cells of 
the limbus region are also positive to K12. In contrast, the basal corneal stem cells in 
the limbus region are both K3/K12 negative [70,71]. Apart from the corneal epithelium, 
the conjunctiva is also known to express K15 in all layers of its epithelium with K19 
expression in its basal layer only [72].  
A fragile detachable epithelium characterizes an absence of cytokeratin 
expression in the corneal epithelial cells due to its loss of mechanical stability [73,74]. 
Interesting findings from several reports show that during corneal insults the expression 
pattern of cytokeratin changes; for ex: 1) debrided corneal epithelium showed K19/K15 
expression with the appearance of goblet cells, that signifies the alteration into 
conjunctival type of epithelium [72]; 2) Dry eye conditions showed corneal epithelium 
with K1/K10 expression, signifying its alteration to skin type of epithelium (non-
keratinized to keratinized type). These conditions are correlated with the development of 
‘squamous metaplasia’ in the corneal epithelium that is characterized with the 
keratinization, loss of mucin expression, increased stratification of cells and 
enlargement of the surface squamous cells [75].   
Corneal stroma (Figure 2) is protected by the overlying dense collagenous 
Bowman’s layer. Stroma is the largest and the thickest (400-500μm) layer of the cornea 
that consists of specialized collagen fibers- ‘lamellae.’ A defined organization of the 
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lamellae contributes to corneal transparency. The lamella is interspersed with 
keratocytes and ground substance (proteoglycans and chondroitin sulfate) that plays a 
role in maintaining the corneal matrix. During corneal wounding, keratocytes undergo 
differentiation to form fibroblast cell type with a capability to migrate to the wound site in 
the presence of contractile actin element and subsequently to myofibroblast phenotype 
of cells with an increased contractile ability due to the expression of α-Smooth Muscle 
Actin (α-SMA). During pathological conditions, corneal epithelial cells, are known to 
secrete growth factors such as transforming growth factor (TGF-β1), epidermal growth 
factor (EGF), fibroblast growth factor (FGF), insulin-like growth factor (IGF-1), which 
binds to their cognate receptors to mediate signal transduction pathways that can alter 
the normal phenotype of the corneal stroma [64,76].    
Corneal endothelium (Figure 2) consists of a monolayer of non-dividing cells 
with a limited regenerative capacity. It mainly functions as a pump between the anterior 
cornea and the posterior aqueous humor to deliver waste out and diffuse nutrients into 
the cornea [63]. 
2.2. Corneal nerves 
The cornea is an avascular tissue; however, it is also a densely innervated 
tissue. Corneal nerves play an essential role in tear production and secretion. 
Additionally, corneal nerves help in wound healing, the blink reflex, and sensations of 
temperature, pain, and touch [77]. It is well known from literature studies that corneal 
nerve dysfunction leads to corneal opacity and loss of vision [78].  Approximately 1.57 
million people worldwide have blindness due to corneal opacity [78]. Corneal nerve 
damage may also occur under inflammatory conditions or in the presence of an 
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infectious corneal disease leading to blindness [79]. From a recent study, it has been 
demonstrated that HSV-1 infection in cornea leads to corneal nerve degeneration [80]. 
Hence, this makes it important to understand the structure and function of corneal 
nerves.  
The ophthalmic branch of cranial nerve V (trigeminal nerve) branches into 
sensory trigeminal neurons to transmit nerve fibers in the cornea and terminate into free 
nerve fiber endings in the corneal epithelium [81]. The nerve fibers from the trigeminal 
ganglion cells branch to form nerve bundles near the limbus. These nerve bundles now 
form the limbal plexus [82]. From the limbal plexus, stromal nerve trunks emerge to 
enter the peripheral corneal stroma in a radial pattern and divides into several branches 
[83]. There are both unmyelinated and myelinated axons in the stromal nerve trunks 
[84]. In the periphery of the mouse cornea there are myelinated nerve fibers, whereas, 
in the periphery and central human cornea, beaded fibers and straight fibers are present 
that are not myelinated and myelinated respectively [82,85]. 
Interestingly, corneal nerve fibers lose their myelin sheath with their outer 
covering ‘perineurium’ only surrounded by Schwann cells that help in conducting nerve 
impulses in the absence of myelination [86]. In the corneal stroma, as the nerve density 
increases anteriorly, the diameter of the nerve also decreases making it thin and leading 
to its branching into smaller fascicles eventually forming the anterior stromal plexus 
[81,87,88]. Corneal stromal nerves are known to innervate keratocytes and are 
organized in parallel to collagen lamellae, while only a few stromal nerves are known to 
terminate as free nerve endings [88]. Defasciculation of stromal nerves may occur as 
they reach the anteriormost of the stroma and into the subbasal nerve plexus reaching 
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into the corneal epithelium. Hence, the innervation in the corneal epithelium is derived 
from the subbasal nerve plexus, which originated from the branches of the peripheral 
stromal nerves [89,90]. In the peripheral cornea, the tips of the stromal nerve enter and 
gives rise to the long bundles of nerves that run into the central cornea, that eventually 
divides into intricate branches to form a network in the corneal epithelium. The fashion 
in which the nerves run into the cornea gives it a form called ‘swirl- like pattern’ 
[83,91,92]. The beaded unmyelinated nerve fibers run through the subbasal plexus and 
terminate into the corneal epithelium as free nerve endings, especially with more dense 
nerve endings in the central cornea [87]. The nerve fibers of corneal epithelium are 
nociceptive fibers that respond to heat, chemical or mechanical stimuli [93]. A response 
to neuropathic pain may also be associated with corneal inflammation [94]. Intriguingly, 
the existence of neurotrophic factors in the cornea is known to maintain a healthy 
corneal surface by modulating inflammation and inducing wound repair [95]. Some of 
the corneal neurotrophic factors include nerve growth factor (NGF), Semaphorin (Sema) 
3A, 3F, and 7A, Slits 1-3, Netrin 2, Ephrin (Eph) B2, Substance P (SP), calcitonin-gene 
related peptide (CGRP), neurotrophin (NT-3) and brain-derived neurotrophic factor 
(BDNF) [96,97]. Substance P is known to be released from the nerve fibers during 
inflammation to promote wound healing and proliferation of corneal epithelial cells [95]. 
Therefore, the absence of neurotrophic factors can significantly affect the corneal nerve 
function.  
To study corneal nerve function, there are indirect tests performed such as; a) 
lacrimation tests, for ex: the Schirmer and phenol red thread tests that assess the tear 
production & quantification of tear volumes, b) Tests with vital dyes, for ex: fluorescein, 
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Rose Bengal and lissamine green to observe the occurrence of  corneal epithelium 
damage [98]. Corneal diseases can be associated with the dysfunction of the corneal 
nerves since the corneal sensory nerves are connected to the central nervous system 
(brain) via afferent nerves while the signals from the brain are received through efferent 
nerves [81]. Apart from the cornea, corneal sensory nerves, and brain, this circuit 
system also comprises the lacrimal glands which complete the neural circuit and has an 
essential role in tear production. Hence indirectly, during corneal damage, malfunction 
of the neural circuit system can cause aberrant tear production. The absence of 
neuropeptides involved in signaling the neural circuit can also cause a direct effect on 
aberrant tear production [99]. It is evident that corneal nerves play an important role in 
maintaining the corneal integrity since damage caused to corneal nerves leads to its 
structural damage for ex: epithelial defect, perforation and reduced transparency 
[100,101]. It is well known from a recent mouse model study that during HSV-1 infection 
in the cornea, the damage is caused to the sensory nerve fibers innervating cornea that 
as observed by the corneal whole mount staining for β-III tubulin (neuronal marker) [80].  
Interestingly, another factor known to involve in corneal nerve formation is the 
Paired box-6 (Pax-6). Pax-6 is a transcription factor that plays a major role in eye 
development including the corneal epithelium. Deficiency in Pax-6 expression results 
into various ocular anomalies, especially leading to corneal opacity, corneal epithelial 
defects, vascularization and discrepancy in the regular corneal nerve pattern [102]. Pax-
6 has also been reported in maintaining normal corneal morphogenesis by controlling 
the cellular adhesion in corneal epithelial cells via the expression of tight junction 
proteins [103]. Therefore Pax-6 has been identified as a role model in keeping a normal 
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healthy corneal epithelium that also functions in maintaining the corneal nerve 
formation. 
2.3. Corneal hem-angiogenesis 
Corneal hem-angiogenesis involves the sprouting of new blood vessels from 
capillaries and venules of pericorneal plexus of the limbal area that receives blood 
supply from the branches of ophthalmic arteries and ciliary arteries [104]. The process 
of corneal angiogenesis can be divided into several phases as follows; 1) the release of 
growth factors under corneal injury and their binding to the cognate receptors present 
on vascular endothelial cells. These cells belong to the neighboring pre-existing blood 
vessels that help in promoting vessel growth. 2) Vascular endothelial cells undergo a 
process of ‘activation’ after migrating away from the parent blood vessel by producing 
proteolytic enzymes to degrade the basement membrane and extracellular matrix. 3) 
Activated vascular endothelial cells acquire the expression of cell surface adhesion 
molecules such as integrins and selectins [105]. 
The cornea under normal conditions, lacks both lymphatic and blood vessels, 
thus maintaining its transparency and visual acuity [106]. An important characteristic 
feature of the normal cornea is to maintain lymphatic and avascularity that also 
influences the “immune privileged” status of the tissue.  The privileged status of cornea 
actively plays a role in maintaining a proper balance between angiogenic and anti-
angiogenic factors in corneal epithelium [104]. Several angiogenic molecules have been 
identified to be expressed in the cornea, most prominently being Vascular endothelial 
growth factor (VEGF-A also called as VEGF) which is increased during inflammation 
and vascularization of the cornea in both human and animal models [104]. VEGF was 
14 
 
 
 
initially named as vascular permeability factor (VPF) for its role as a stimulator of 
vascular permeability. VEGF plays a crucial role in angiogenic events during embryonic, 
physiologic, and pathological blood vessel growth in vivo104. VEGFs belong to a family 
of secreted polypeptides with VEGF-A as a primary member of the family [104,107]. 
Additionally, VEGF-B, VEGF-C, and VEGF-D are the other members of the family that 
differentially bind to VEGF receptors (VEGFR). VEGF-A binds to VEGFR-2 (also called 
Flk-1) and VEGFR-1 (also called Flt-1), VEGF-C and VEGF-D bind to VEGFR-3 while 
VEGF-B only binds to VEGFR-1 [104]. Recent studies have shown the expression of 
VEGF localized to corneal epithelial and endothelial cells, vascular endothelial cells of 
limbal vessels and keratocytes [104,105]. Normal cornea constitutively expresses 
VEGFR-1 that binds to VEGF-A a potent angiogenic stimulator and VEGFR-3 
specifically by corneal epithelium that binds to angiogenic VEGF-C and VEGF-D. 
Additionally, there are also other critical anti-angiogenic molecules expressed by 
corneas such as thrombospondin-1 (TSP-1), endogenous IL-1 receptor antagonist (IL-
1Ra) and Tissue inhibitor of metalloproteinases (TIMPs)-1 and 2. Therefore, these 
factors help in maintaining corneal avascularity by inhibiting both hem-angiogenesis and 
lymphangiogenesis. However, under inflammatory conditions such as HSK, increased 
expression of VEGF has been reported, particularly by the epithelial cells of both 
inflammed and vascularized cornea [108].  
3. Hypoxia Inducible factor 
3.1.HIF Pathway 
Identification of hematopoietic growth hormone EPO led to the discovery of HIF 
as a key regulator of hypoxia’ that can either directly or indirectly regulate gene 
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expression involved in controlling metabolic adaptations, erythropoiesis, angiogenesis, 
apoptosis and other cell survival processes [109]. HIF is a widely known transcription 
factor with three different alpha isoforms namely HIF-1α, HIF-2α, and HIF-3α all that are 
sensitive to oxygen tension; while the HIF-1β isoform is constitutively expressed. HIF-1β 
is not oxygen responsive and forms heterodimeric complexes with one of the alpha 
isoforms. Both HIF-1α and HIF-2α play a major role in upregulating angiogenic factors 
during hypoxia [110]. Under normal oxygen tension (normoxia) HIF undergoes a 
hydroxylation process. In contrast, under hypoxic conditions, HIF stabilizes in the 
nucleus forming a heterodimer with HIF-1β that triggers the activation of genes involved 
in both physiological and pathological conditions [111].  
HIF-1β is constitutively expressed and forms a heterodimeric complex with one of 
the three isoforms of HIF namely, HIF-1α, HIF-2α, and HIF-3α which are upregulated 
during hypoxia [112]. Each of these alpha isoforms contains functional domains, with an 
individual specific role in dimerization (bHLH/PAS), nuclear localization signal (NLS), 
protein stability (ODDD-N-TAD), and transcriptional activity (N-TAD/C-TAD); bHLH –
basic helix loop helix domain; PAS= Per-Arnt-Sim motif; NLS= nuclear localization 
signal; ODDD= oxygen-dependent degradation domain; N-TAD= N-terminal 
transactivation domain; C-TAD= C-terminal transactivation domain [113]. Prolyl 
hydroxylase enzymes (PHD1-3) play an important role in regulating the HIF pathway 
since it functions as the oxygen sensor in the cells [114]. During normoxia, PHD 
enzyme hydroxylates ODDD of HIF-α that initiates the binding of von Hippel-Lindau E3 
ubiquitin ligase complex to ubiquitinate HIF-α and thereby promoting it to proteasomal 
degradation [115] (Figure 4). In contrast, under hypoxia, HIF-α accumulates in the cell 
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followed by its nuclear translocation to form a transcriptional complex with co-activator 
proteins p300 and CBP. The transcriptional complex consists of the dimers HIF-α- HIF-
1β that binds to the HRE (hypoxia response element) within the promoter of target 
genes. The transcribed genes mediate angiogenesis, cell motility, metabolism, 
apoptosis, proliferation, and other cellular functions in response to hypoxia [116]. In a 
nutshell, under normoxia, HIF-α degradation is regulated via hydroxylation mediated by 
the VHL binding, while under hypoxia HIF-α accumulation in the nucleus and its 
transcriptional activity is mediated by the binding of p300/CBP to HIF-α [117]. 
4.  Lacrimal gland 
4.1. Anatomy and functional role of the lacrimal gland 
The lacrimal functional unit (LFU) consists of the lacrimal gland, conjunctiva, 
cornea and interconnecting innervations [118]. The aqueous layer of the tear film is 
contributed by the lacrimal gland that is essential to maintain a healthy ocular surface, 
especially the corneal and conjunctival tissue [99]. The prominent lacrimal gland in mice 
and rats is the exorbital lacrimal gland located below the ear which is connected to the 
ocular surface by the excretory duct [119]. The main secretory cells in lacrimal gland are 
the pyramid-shaped acinar cells that are linked together by tight junctions to form the 
racemous glands [99] (Figure 5). The intralobular and interlobular lacrimal ducts consist 
of duct cells that help in the modification of the primary products of the lacrimal gland 
with water and electrolytes from acinar cell secretions [120]. Another main cell type in 
the lacrimal gland is the myoepithelial cell that expresses α smooth muscle actin. These 
myoepithelial cells surround the acinar and ductal cells and functions via its contraction 
to help excretion of the lacrimal gland fluid [99,120]. Apart from these cell types, the 
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existence of immune cells has also been studied, including lymphocytes, dendritic cells, 
macrophages, and plasma cells. Under pathological conditions, lymphocyte populations 
are reported to increase their population [121]. Intriguingly, the secretion from a lacrimal 
gland (tubuloacinar exocrine gland) is tightly regulated by the neural reflex. The 
mechanism of neural response occurs via the activation of afferent sensory nerves in 
the cornea and conjunctiva that stimulates the efferent nerves (parasympathetic and 
sympathetic nerves) innervating the lacrimal gland. The efferent nerve stimulation, in 
turn, helps in the release of the neurotransmitters from the nerves innervating lacrimal 
glands and promotes secretion from the lacrimal glands onto the ocular surface. The 
thin myelinated sensory nerve endings in the ocular surface help in stimulating the 
lacrimal gland to secrete the aqueous layer of the tear film [122,123].  These nerves 
lose their myelin sheath as they enter the corneal stroma, where they undergo intricate 
branching into the subepithelial plexus. Eventually, these nerves branch out further as 
thin nerves into the corneal epithelium that ultimately terminates in the apical layers of 
the corneal epithelium forming a ‘leash type of nerve endings’ [40]. The sensory nerves 
that are present very close to the corneal surface will help in sensing changes in the 
tear film due to stress or environmental changes [81]. Therefore, the regulation of 
lacrimal gland secretion is controlled by the ‘neural reflex arc’ that involves the 
activation of sensory nerves in both cornea and conjunctiva [124]. There are three major 
steps involved in the neural regulation of lacrimal gland function; (i) sensory nerve 
activation in the cornea and conjunctiva: corneal sensitivity is the prime factor for tear 
secretion since sensory nerves play a major role in stimulating tear secretion from the 
lacrimal gland. Under conditions such as corneal lesions, microbial keratitis, or epithelial 
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defects, reduced corneal sensitivity has been reported to be associated with decreased 
tear production [125]. (ii) Efferent parasympathetic and sympathetic nerve stimulation: 
neurotransmitters such as acetylcholine and norepinephrine are released upon both 
parasympathetic and sympathetic nerve stimulation respectively, to control secretion 
from the lacrimal gland. Acetylcholine binds to muscarinic receptors, whereas 
norepinephrine binds to an adrenergic receptor to further initiate the signaling pathways 
[126]. Despite the presence of efficient afferent neural stimulation, neurotransmitter 
release is critical in lacrimal gland secretion. During lacrimal inflammation, a decrease in 
tear production is observed due to the blockage of neurotransmitter release and 
disabled efferent nerve stimulation [127]. (iii) Signaling pathways in lacrimal gland: in 
addition to the neurotransmitter release, signaling pathways activated by its binding to 
cognate receptors is also essential in stimulating lacrimal gland secretion. The inhibition 
of the signaling pathway was observed when antagonists were bound to muscarinic 
receptors and thereby prevents the binding of acetylcholine leading to inefficient efferent 
nerve stimulation [121]. 
In summary, the neural reflex arc is known to involve in ‘cross-talk’ between 
ocular surface and lacrimal gland by activating the afferent sensory nerves in the 
cornea and conjunctiva that promotes the activation of efferent sympathetic and 
parasympathetic nerves. This cascade of events is crucial to signal tear secretion from 
lacrimal gland [124].   
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5.  Conjunctiva 
5.1. Anatomy and functional role of the conjunctiva 
Conjunctiva is a semitransparent thin mucous membrane that covers the 
posterior surface of the eyelids, connects with the eyeball and eventually extends into 
the limbus of the cornea. It is highly innervated and vascularized tissue that functions in 
protecting the cornea by secreting mucins, antibacterial proteins, water, and electrolytes 
which forms both an aqueous and mucous layer of the tear film [128]. Importantly, 
conjunctiva plays an essential role in absorbing drugs (permeable to 40KDa) and 
actively transports via sodium-dependent, monocarboxylate or dipeptide transporters to 
the ocular surface [129,130]. Conjunctiva is anatomically subdivided into three 
subdivisions; (1) Tarsal or palpebral conjunctiva lining the eyelids (2) Forniceal 
conjunctiva lining the upper and lower fornices (3) Bulbar conjunctiva overlying the 
sclera. Conjunctiva consists of the non-keratinizing epithelium with mucin-secreting 
goblet cells and eventually becomes continuous with the corneal epithelium [131] 
(Figure 6). From a plethora of studies, it is evident that under corneal epithelial cell 
damage, limbal stem cells will help in corneal re-epithelization. Interestingly, during 
damage to the limbus, development of corneal angiogenesis and migration of goblet 
cells in the newly formed corneal epithelium was observed [132]. Rich innervations in 
conjunctiva occur via parasympathetic and sympathetic nerves surrounding conjunctival 
goblet cells, whereas the sensory nerves innervate the conjunctival epithelial cells 
[133,134]. Therefore, corneal sensory nerves will help to promote neural reflex to 
stimulate parasympathetic nerves and mucin secretion from conjunctiva [135]. 
Conjunctival epithelial cells synthesize membrane-bound mucins MUC- 1, -2 -4, -7 and -
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16. MUC-4 is also reported to be secreted as soluble mucin by releasing itself into the 
tear film via ‘ectodomain shedding’[128]. Gel-forming mucin, MUC5AC is synthesized 
and secreted by the conjunctival goblet cells [136]. 
Altogether, this study broadens our knowledge on understanding first, an intricate 
network of lacrimal gland inflammation during HSV-1 infection in mouse cornea and its 
influence on tear secretion, correlating to the maintenance of corneal epithelial integrity 
and second, the mechanisms of hypoxia-induced angiogenic mediators in HSV-1 
infected mouse cornea. More importantly, this study will also help us to identify novel 
strategies for maintaining corneal integrity, to increase and sustain stable tear volume to 
alleviate HSK disease severity and thereby control corneal blindness. 
6. Insulin-like growth factor binding protein (IGFBPs) 
6.1. Insulin growth factor (IGF) and IGFBP-3 
Cell survival depends on a balance maintained between the signals that mediate 
cell survival and apoptosis. The IGF axis has a unique role to play in managing both 
signals. IGF has a prominent role in mediating cell survival factors by binding to IGF-1R 
[137]. The IGF system constitutes peptides called Insulin-like growth factors (IGFs), 
which are produced in the liver and possess mitogenic activity by interacting with 
Insulin-like growth factor receptors (IGFRs). IGFs are of two types that are structurally 
similar to insulin, namely IGF-I and IGF-II that are regulated by IGFBPs and IGFBP 
proteases [138]. It will be interesting to understand the role of IGFBPs in the regulation 
of IGF during corneal HSV-1 infection if any. A 150KDa ternary complex is formed when 
IGFBP interacts with the acid -labile subunit (ALS) glycoprotein and the free IGF in 
serum. This interaction of IGFBPs and IGF inhibits the binding of IGF to its cognate IGF 
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receptor [139]. From the sequencing studies, six different isoforms of IGFBPs have 
been identified; IGFBP-1 to IGFBP-6. Among these IGFBP-3 has been reported to be 
highly abundant in the serum that can predominantly bind to the free IGF-I/IGF-II in the 
serum [140,141]. It has been shown that 1% of the circulating IGF-1 remains in the free 
state, while the rest is bound mainly to IGFBP-3 [142]. IGF-1 action can be modulated 
by  IGFBP-3 either positively or negatively depending on the tissue, and it’s the 
pathologic state [143]. In tumor models, IGFBP-3 has been widely studied to promote 
different functions, either apoptosis or support cell survival signals [144]. The binding of 
IGFBP-3 to IGF-1 is inhibitory, since it reduces the bioavailability of IGF-1 to promote 
mitogenic effects but leads to induce apoptosis. On the contrary, IGFBP-3 binding to 
IGF-1 will control IGF-II function positively by slowly releasing the IGF-1 to its binding 
receptor IGF-1R. Therefore, IGFBP-3 will help in coordinating the exposure of IGF-1 to 
IGF-1R in a well-regulated manner to promote downstream cell survival signaling [137]. 
The IGF-1R is a transmembrane heterotetrameric protein, which has two extracellular α-
chains and two membrane-spanning β-chains in a disulfide-linked β-α-α-β configuration 
[145,146].  
The affinity of IGFBP-3 to IGF-1 reduces when IGFBP-3 is proteolyzed into 
fragments and thereby letting the IGF-1 free [147]. Apart from this, IGFBP-3 is also 
known to act independently of IGF-1 and functions to promote apoptosis triggered by 
p53, TGF-β1/TGF-β2 [148]. IGFBP-3 exists as a cleaved form in specific tissues such 
as the vitreous humor of diabetic patients, providing the identification of IGFBP-3 
protease [149].In the cornea, IGFBP-3 has been reported to function in myofibroblast 
proliferation and differentiation [150]. The membrane-bound expression of IGFBP3 in 
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basal and suprabasal cells of central human corneal epithelium were observed in 
addition to its increased expression in the surface epithelial cells, thus signifying its role 
in cell surface shedding and apoptosis. Prominent expression of IGFBP3 in the basal 
cells of peripheral corneal epithelium also indicates its function in the ‘centripetal 
migration’ of epithelial cells [151]. IGFBP-3 has also been shown to have a potential role 
in apoptosis and anti-growth signaling in the human corneal epithelium [151].In this 
study, we will further determine the role of the IGF-1/IGFBP-3 axis in the development 
of corneal hem-angiogenesis and HSK disease severity.  
6.2. IGF dependent action of IGFBPs 
IGF dependent activity of IGFBPs involves sequestration of IGFs. This results in 
the rescue of IGF binding to its receptor (IGF-R) [152,153]. A plethora of reports has 
reported evidence on the interaction between IGFBPs and IGF [154,155,156]. This 
defines the IGF-dependent mechanism of IGFBPs which modulates the bioavailability of 
IGF (Figure 7). Binding of IGF molecules to IGF-1R activates intracellular tyrosine 
domain of β-chain and causes autophosphorylation at several tyrosine residues in IGF-
1R [145]. Phosphorylation of tyrosine residues 1131, 1135, and 1136 plays an essential 
role in canonical signaling attributed to the receptor [157]. Activated IGF-1R 
phosphorylates insulin receptor substrates (IRS-1 and IRS-2) and initiates signaling 
cascade. This signaling cascade includes the activation of phosphatidylinositol-3-kinase 
(PI3K)/AkT and mitogen-activated protein kinase pathways [158]. IGF-1R signaling has 
been well reported to have pleiotropic effects, which includes enhancing cellular 
proliferation, migration, neutrophil survival, and effector function, T-cell survival, 
promoting hem- and lymphangiogenesis and inhibition of apoptosis [159,160,161]. 
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The IGF dependent action of IGFBPs was demonstrated by using a recombinant 
human mutant of IGFBP-4 that showed a reduced activity to bind IGF-2 molecules. This 
reduced binding resulted in the inhibition of osteoblast proliferation [162]. Additionally, 
IGF dependent action of IGFBP was also evident from the release of IGF molecules 
either by proteolysis of IGFBPs or by alterations in the IGFBP phosphorylation. IGFBP-3 
levels in serum have reported being regulated by the protease activity such as plasmin 
and serine proteases (Prostate-specific antigen), which degrades IGFBP-3 [154]. Matrix 
metalloproteinases (MMPs) are the enzymes known to have proteolytic activity and is 
involved in the degradation of IGFBPs. MMPs are the family of Zn2+- dependent 
enzymes that are involved in the remodeling of extracellular matrix components [163]. 
They are synthesized as proenzyme molecules and become active after removal of an 
amino-terminal pro-peptide. MMP-3 and MMP-9 are reported to trigger the proteolysis of 
IGFBP-3 resulting in the release of IGF molecules [164,165,166]. Interestingly, 
increased IGFBP-3 proteolysis has been reported in pathological conditions such as 
cancer and arthritis [167]. Previous studies have shown that MMP-3 and MMP-9 are 
involved in the proteolysis of IGFBP-3 in inflamed tissue [168,169]. Interestingly, in the 
mouse model of HSK, the expression and activity of MMP-9 have been reported in 
HSV-1 infected corneas [170]. While, the reports from our lab showed an increased 
level of both, MMP-9 and MMP-3 during the pre-clinical and clinical phase of HSK 
(Figure 37). MMP-3 serves as an activator of pro-MMP-9 and helps in the generation of 
active MMP-9 [171]. Overall, these studies provide evidence on the proteolysis of 
IGFBP-3 in inflamed tissue via MMPs that leads to the release of the bound IGF 
molecules.  
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6.3. IGF independent action of IGFBPs 
IGFBPs can execute its function independent of IGF binding and also by not 
influencing IGF receptor signaling (Figure 7). Structurally IGFBP-3 consists of a 
conserved N-terminal domain, a mid-region that is highly variable, and a conserved C-
terminal domain, with other subdomains and functional motifs which helps in the 
functional role of IGFBP-3 [172]. The mid-region of IGFBP-3 essentially plays a role to 
promote its interaction with glycosaminoglycans (cell surface proteins) [173]. Recent 
reports have suggested the specific binding of IGFBP-3 to cell surface receptor (not the 
IGF receptor) in breast cancer cells which mediated growth inhibition in these cells. 
Additionally, studies have also reported various types of receptors interacting with 
IGFBPs such as type V TGFβ receptor. IGFBP-4, and -5 is known to interact with type V 
TGFβ receptor in breast cancer cells [174,175]. Type V TGFβ receptor was found to be 
structurally similar to the low-density lipoprotein receptor-related protein-1 (LRP-1) 
[176]. The report suggested that binding of IGFBP-3 to Type V TGFβ/ LRP-1 promoted 
growth inhibitory signaling in human lung carcinoma cells (H1299) [177]. A recent study 
has provided evidence on the involvement of the IGFBP-3 receptor with IGFBP-3 
functions in retinal endothelial cells mediating apoptosis [176].   
Several reports have demonstrated the IGF independent action of IGFBP-3, and 
-5 via its localization to the nucleus [178]. Localization of IGFBP-3 into the nucleus has 
been reported due to the presence of a nuclear localization signal (NLS) and the 
nuclear transport protein importin-β. Once in the nucleus, IGFBP-3 executes 
transcription regulation. IGFBP-3 can also bind to nuclear receptors such as retinoid-x-
receptor-α, Vitamin D receptor, peroxisome proliferator-activated receptor-γ (PPAR-γ), 
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Nur -77 [179]. Furthermore, the nuclear localization of IGFBPs is also known to promote 
the anti-apoptotic effect [180]. IGFBPs also binds to the epidermal growth factor 
receptor (EGFR) on the plasma membrane and then translocate into the nucleus in 
response to DNA damage and promotes DNA damage repair [181]. IGFBPs may likely 
promote cell adhesion and motility in an IGF independent manner. IGFBP-1, and -2 is 
known to bind integrin α5β1 (fibronectin receptor) to promote cellular growth signaling 
pathway [152]. Moreover, a plethora of reports have indicated the IGF independent 
action of IGFBP-3 in mediating cellular growth and angiogenesis in diabetes 
[182,183,184]. Taken together, the reports have provided concrete evidence on the 
IGF/IGF-R independent action of IGFBP-3 executing either promoting or inhibiting 
various cellular processes such as cellular proliferation, growth, and apoptosis.
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Figure 1: Key aspects of Herpes Stromal Keratitis (HSK) development in C57BL/6 mouse 
model. The early response to control the virus occurs during the pre-clinical phase. The 
actively replicating virus ceases by day 7 post-infection. An influx of inflammatory neutrophils is 
detected during the pre-clinical phase. The disease pathology begins to develop during the 
clinical phase of the disease (after day 7 post -infection) with the development of hem-
angiogenesis and corneal opacity. An increased influx of T-cells is detected. Additionally, 
another wave of neutrophil influx is also observed at the clinical disease phase. Therefore, 
there is a biphasic infiltration of neutrophils during the pathogenesis of HSK disease.  
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Figure 2: Structure of Cornea. Layers in cornea showing from the top (anterior) 
corneal epithelium layer, Bowman’s layer, corneal stroma, Descemet’s membrane, and 
endothelium at the bottom (posterior) 
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Figure 3: Layers of tear film. Tear film overlying the corneal epithelium. Membrane 
bound mucins on the corneal epithelium function as glycocalyx at the epithelial-tear film 
interface. Three layers of tear film from the top (anterior) is the lipid layer, middle 
aqueous layer (with soluble mucins), at the bottom (posterior) mucous layer.  
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Figure 4: Regulation of Hypoxia Inducible Factor (HIF) pathway in oxygen dependent 
manner. In presence of abundant oxygen (normoxia) HIF-1/2α (HIF isoforms) is prone to undergo 
proteasomal degradation. This process is initiated by the prolyl hydroxylases (PHD) followed by 
the binding of HIF isoforms to von-Hippel-lindau (VHL). However, under low oxygen supply 
(hypoxia), stabilization of HIF isoforms occurs upon its translocation to the nucleus. 
Heterodimerization of HIF isoforms occur in the nucleus with HIF-1β, along with the cofactor 
protein (p300/CBP). This heterocomplex formed in the nucleus promotes the transcription of HIF 
target genes that consists of hypoxia response element (HRE) sequences in their promoter 
region. (CBP-CREB-Binding protein)   
Modified concept from Franke.et.al; Erythrocytosis: the HIF pathway in control; Blood; 2013 
122(7):1122-8.  
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Figure 5: Histology of Extra-orbital Lacrimal gland from a C57BL/6 mouse. The image is showing the 
histology of Extra-orbital lacrimal gland from C57BL/6 mice which was stained with Hematoxylin and 
Eosin (H&E). The image shows lobules separated by loose connective tissue (arrows are indicating the 
location). Each of these lobules consists of acini (arrows highlighting the acini within the lobules). An 
enlarged image of the acinus is shown in the image on the right, indicating acinar cells that are secretory 
in function. The lobules also contain ducts (an enlarged image displayed on the right) that helps in 
transporting the secreted components from the lacrimal gland.  
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Figure 6: Histology of Conjunctiva from a C57BL/6 mouse. The image is showing the histology of 
conjunctiva from C57BL/6 mice which were stained with Periodic acid-Schiff (PAS). A. The image shows 
the location of the conjunctiva in the cross-section of the Adnexa. B. An enlarged image is showing three 
different types of the conjunctiva. The one highlighted in the red is the bulbar conjunctiva or the ocular 
conjunctiva (covers the outer surface of the eye), highlighted in blue is the palpebral or the tarsal 
conjunctiva (lines the inner side of eyelids), highlighted in green is the fornical conjunctiva (present at the 
junction between the bulbar and palpebral conjunctiva). C. An enlarged image showing the goblet cells 
(PAS+) lined across the conjunctival epithelium.   
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Figure 7: Insulin Like Growth Factor (IGF) dependent and independent action of 
Insulin Like Growth Factor Binding Proteins (IGFBPs). In the left panel, showing the 
binding of IGF-1 to its receptor IGF-1R. This elicits the signaling cascade upon 
phosphorylation of the IGF-1R receptor. While, the presence of IGFBPs modulates the 
IGF signaling by its binding to the IGF molecules. This leads to the sequestration of the 
IGF molecules and inhibits its binding to the IGF receptor. On the right panel, showing 
IGBPs interaction with the cell surface receptors such as LRP-1/type V TGF-β receptor. 
Other cell surface receptors yet needs further elucidation. It is known that, IGFBPs upon 
its binding with the cognate receptor leads to its internalization inside the cell and gets 
transported into the nucleus in an importin-dependent fashion, thereby to promote the 
expression of specific genes involved in various cellular process (migration, proliferation, 
apoptosis etc).  
Modified concept from Wick.et.al; A Darwinian-evolutionary concept of age-related 
diseases; Experimental Gerontology 38 (2003) 13–25 
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MATERIALS AND METHODS 
Mice 
Eight- to twelve-week-old C57BL/6 mice were purchased from Jackson 
Laboratories (Bar Harbor, ME). This mice strain (stock No 000664) was used for all 
experiments mentioned in this study. IGFBP-3-/- mice were provided by Dr.Jena Steinle 
laboratory (Wayne State University School of Medicine, Dept of Ophthalmology, Visual 
and Anatomical Sciences). The genotype of IGFBP-3-/- mice was confirmed (Figure 8). 
All mice were housed at Wayne State University School of Medicine, Division of Animal 
Laboratory Animal Resources (DLAR). All experimental animal procedures were 
reviewed and approved by the Investigation Animal Care and Use Committee (IACUC) 
of Wayne State School of Medicine and the Association for Research in Vision and 
Ophthalmology. 
Virus 
HSV-1 McKrae was obtained from Dr.Daniel J.J. Carr laboratory at the University 
of Oklahoma College of Medicine (Oklahoma City, OK). In our laboratory, the virus was 
propagated on a monolayer of Vero cells (American Type Cell Culture, Manassas, VA; 
CCL81). Infected Vero cells were then pelleted by centrifugation at 3000rpm for 30min 
at 4°C. The pellet was resuspended in 2ml PBS and then subjected to three cycles of 
flash freeze/thaw in liquid nitrogen and in 37°C water-bath, respectively. The virus was 
purified from the supernatant and then titrated to quantify the viral titers using viral 
plaque assay. Viral titers were designated as plaque forming units per milliliter (pfu/ml). 
Aliquots of the virus were stored in -80°C until used [185]. 
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Corneal HSV-1 infection 
Primary HSV-1 infection in C57BL/6 mice was performed by anesthetizing the 
mice with an intraperitoneal injection of ketamine/xylazine (33mg/kg body 
weight/20mg/kg body weight respectively) in 0.2 ml of 1x phosphate buffered saline 
(PBS).  Mouse corneas were sacrificed using a 27 ½ gauge needle. 1x105 pfu of HSV-1 
McKrae virus was topically applied only to the right cornea in 3ml of 1x PBS. All infected 
mice were housed in micro-isolator cages with cage tops and handled in Class II, Type 
A2, biosafety cabinet to aid precaution against bacterial superinfection [186]. 
Clinical Scoring of Herpes Stromal Keratitis (HSK) 
Handheld slit lamp biomicroscope (Kowa, Nagoya, Japan) was used to clinically 
score each of the HSV-1 infected eyes at day 8, day 10 and day 16 post HSV-1 
infection, to determine corneal opacity and development of corneal angiogenesis. A 5-
point scale is applied to determine the severity of corneal opacity as follows: 0-normal 
cornea; 1-mild corneal haze; 1.5- mild corneal haze and with epithelial defect; 2.0- 
moderate opacity with iris visible; 2.5- moderate opacity with iris visible and with 
epithelial defect; 3.0- severe opacity with iris not visible; 3.5- severe opacity with iris not 
visible and with epithelial defect; 4.0- severe opacity with corneal ulcer; 4.5- severe 
opacity with corneal ulcer and with epithelial defect; 5.0- corneal rupture. Corneal hem-
angiogenesis was determined by measuring the centripetal growth of newly formed 
blood vessels in each quadrant of the cornea as follows; A 4-point scale is applied to 
determine the length of the blood vessels in each quadrant of the cornea between 0- 
with no angiogenesis and 4-the blood vessels that reach central region of the cornea. 
The final score from all four quadrants was summed up to have a total range 0-16 score 
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for each eye at a designated time-point. Corneas with an angiogenesis score >4 and 
opacity score >2 were scored as severe HSK, whereas the corneas with an opacity 
score ≤2 and angiogenesis score ≤4 were scored as mild HSK disease [185,187].    
Evaluation of Corneal Smoothness 
Stereomicroscope imaging with the LED ring illuminator (Leica Microsystems Inc, 
IL, USA) was used to capture mouse eye images on day 4, day 8, and day 10 post 
HSV-1 infection to determine corneal smoothness and epithelial defects. The light from 
the ring illuminator projects off the corneal surface and the regularity of the circular ring 
can be determined depending on the smoothness of the corneal surface. The corneal 
smoothness is determined by dividing the projected ring into four quarters, of 3’o clock 
position each quarter. Based on a 5-point scale, the severity of corneal irregularity will 
be scored depending on the number of distorted quarters as follows: 0-No distortion; 1-
distortion in one quarter of the ring; 2- distortion in two quarters of the ring; 3- distortion 
in three quarters of the ring; 4- distortion in all four quarters of the ring; 5-severe 
distortion with no ring formation observed [188,189], 
Phenol red thread tear test 
This test was used to measure the tear levels in each of the HSV-1 infected 
mouse eyes at day -4, -6, -7, -8 and -10 post HSV-1 infection. Each of the un-
anesthetized mice was held on a stable surface (without touching the facial region or 
whiskers) to insert the phenol red (pH indicator) impregnated cotton thread tip (ZQ 
1010, ZONE-QUICK, Japan) into the eyes at the lateral canthus region for the 30s 
(Figure 9). An eye dressing forceps (Miltex, 18-779) was used to hold the thread. 
Appropriate care is taken to avoid touch stimulation to eyelashes and whiskers. The 
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change in the thread color from yellow to red was measured in millimeters and 
recorded. The thread images with color change were captured immediately [190]. 
Rose Bengal staining 
Rose Bengal staining was used to evaluate the damage to the ocular surface in 
HSV-1 infected eyes.1% Rose Bengal (catalog #330000 Sigma Aldrich, MO, USA) 
solution was prepared in distilled water. 2µl of the solution was dropped on to the 
anesthetized mouse eyes by using a micropipette. After 4 secs, Rose Bengal staining 
was washed away from the mouse eyes by using 2µl 1x PBS from the micropipette. The 
eye images were acquired by using stereomicroscope. Positively stained areas with 
Rose Bengal will appear as magenta/dark pink punctate staining on the ocular surface 
[191].   
Immunofluorescence staining and confocal microscopy 
Immunofluorescence staining was performed on day 4, day 10 and day 12 post 
HSV-1 infection and on uninfected (naïve) corneal frozen sections (8µm). Enucleated 
eye-globes from naïve, day 4 and day 10 post-infection were transferred into the blocks 
with OCT compound (Tissue Tek, CA, USA) that were snap-frozen in liquid nitrogen and 
stored at -80ºC.  Corneal frozen sections of 8µm were collected on a positively charged 
glass slide (Thermofisher Scientific, MA, USA). The samples were air dried for 30min 
and later fixed using 2% buffered paraformaldehyde (PFA) for 30min at room 
temperature or with acetone (ice-cold) for 10min at -20ºC followed by three washes in 
1X PBS for 5min each. Slides were blocked using 3% BSA in 1xPBS with 0.3% Triton 
X-100 for 2 hours at room temperature. Slides were then incubated with FITC-
conjugated mouse monoclonal antibody, raised against the pimonidazole adducts 
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formed during hypoxia or with cytoskeletal intermediate filament proteins (K1, K10, K12, 
pan-cytokeratin), paired box-6 protein (PAX-6), hypoxia-inducible factor-1α, 2α (HIF-1α, 
HIF-2α), glucose transporter-1, 3 (GLUT-1, GLUT-3), monocarboxylate transporter-4 
(MCT-4) and Insulin-like growth factor -1 receptor (IGF-1R).  The next day, slides were 
washed for three times in 1x PBS for 5min each, later incubated for 2hr at RT with 
respective secondary antibody (Alexa 488). Slides were rewashed three times in 1X 
PBS for 5min each and then mounted with DAPI containing medium (Vector 
Laboratories, Burlingame, CA) [186,192]. The sources of antibody and dilution used in 
this study are provided in Table 2. Images were acquired in 20x and 40x objective lens 
by using Leica True Confocal Scanner SP8 Confocal microscope (Leica Microsystems 
Inc, IL, USA). 
Corneal whole mount staining and confocal microscopy 
Mice were euthanized at day 4 and day 10 post HSV-1 infection to enucleate the 
eye globes. The eye-globes were then immediately fixed in 4% PFA for 30min at room 
temperature. The corneal tissue was gently dissected (under a dissecting microscope) 
separating it from the attaching iris tissue, ciliary body, scleral tissue, and the lens by 
using fine curved forceps (Miltex, York, PA). The corneal tissue dissected as a ‘cup 
shape’ (Figure 10) was flattened by making six- eight partial cuts from the limbus to the 
central cornea and the stored in 30% sucrose using 0.1% EDTA-0.01% hyalurodinase 
type IV-S solution at 37ºC for 90min. The tissues were blocked using 3% BSA in 1% 
TritonX-100 solution for 90min at room temperature, followed by incubation with primary 
antibody (Tuj1) in a humidified chamber for 16hours at 4ºC. The next day, tissues were 
washed for four times with 0.3% TritonX-100-PBS solution for 10min each, followed by 
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overnight incubation with secondary antibody (Alexa 488) at 4ºC. The next day, tissues 
were washed for four times with 0.3% TritonX-100-PBS solution for 10min each and 
later mounted with DAPI containing mounting medium (Vector Laboratories, 
Burlingame, CA, USA) [190]. The sources of antibody and dilution used in this study are 
provided in Table 2. Tile scan Images were acquired using a Leica True Confocal 
Scanner SP8 Confocal microscope (Leica Microsystems Inc, IL, USA). 
Bromodeoxyuridine (BrdU) incorporation assay 
Naïve(uninfected) and HSV-1 infected mice at day 5 and day 9 post HSV-1 
infection were given a single dose of intraperitoneal injection (0.2ml/mice) of BrdU 
(10mg/ml) in saline solution. Mice were euthanized post 18hrs of BrdU injection, and the 
eye-globes were collected to snap- freeze in the OCT compound (Tissue Tek, CA, 
USA). Frozen sections of the cornea were collected on a positively charged glass slide 
(Thermo Scientific, MA, USA). The sections were let to air-dry overnight at room 
temperature and later fixed in 4% buffered para-formaldehyde solution for 15min, later 
washed thrice in 1xPBS. For antigen retrieval, sections were immersed in Coplin jar with 
2NHCl for 30min at room temperature and subsequently neutralized with 0.1M Borate 
buffer (pH 9.0), twice for 5min each. The samples were blocked with 3% BSA in 1xPBS 
and incubated at 4ºC with primary antibody for 18hrs (overnight). The next day slides 
were washed three times followed by incubation with secondary antibody (Alexa 488) 
overnight at 4ºC. The next day, slides were washed and mounted with DAPI mounting 
medium (Vector Laboratories, Burlingame, CA, USA) [190]. The sources of antibody and 
dilution used in this study are provided in Table 2. Images of 20x and 40x magnification 
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were acquired using Leica True Confocal Scanner SP8 Confocal microscope (Leica 
Microsystems Inc, IL, USA). 
Hematoxylin and Eosin (H/E) and Periodic-Acid-Schiff (PAS) hematoxylin staining 
Extra-orbital lacrimal glands (Figure 11) and Adnexa (Figure 12) from the naïve, 
day 4 and day 10 post HSV-1 infection were dissected and immediately fixed (in 
‘Excalibur’s alcoholic fix solution’). The fixed samples were sent to the core facility 
(Excalibur Pathology, OK, USA) to carry out paraffin embedding, sectioning, H/E 
staining for Extra-orbital gland tissue samples and PAS staining for conjunctival goblet 
cells (from Adnexa tissue sample). Images were acquired by using the Leica light 
microscope (Leica Microsystems Inc, IL, USA). 
Tissue Processing for Flow cytometry (FACS) 
Enucleated eyes from the naïve and infected mice at day -4, -10, -12 and -13 
post HSV-1 infection were collected in ice-cold RPMI 1640 medium supplemented with 
antibiotics and fetal bovine serum (10%). The corneal tissue was dissected (under a 
dissecting microscope) separating it from the attaching iris tissue, ciliary body, scleral 
tissue, and the lens by using fine curved forceps (Miltex, York, PA). Each of the cornea 
samples was collected in ice-cold RPMI 1640 media + Liberase TL (2.5mg/ml, Sigma-
Aldrich, MO, USA) and placed in a disruptor (1500rpm) at 37ºC for 45min. Each of the 
cornea samples was triturated using 3ml syringe plunger and passed through a 70µm 
cell strainer. The samples were pelleted by centrifugation at 1000rpm for 10min (4ºC) 
and then broken down into single cell suspension for FACS staining. 
The mouse Extra-orbital lacrimal gland (EoLG) present anterior to the ear, from 
the naïve and infected mice at day 4 and day 10 post HSV-1 infection were collected 
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(Figure 11) in ice-cold RPMI 1640 media supplemented with antibiotics and fetal bovine 
serum (10%). Individual EoLG tissue was minced into 4-5 pieces and then were 
collected into RPMI 1640 media + Liberase TL (2.5mg/ml, Sigma-Aldrich, MO, USA). 
These samples were placed in a disruptor (1500rpm) at 37ºC for 45min. Each of the 
EoLG samples was triturated using 3ml syringe plunger and passed through a 70µm 
cell strainer. The samples were pelleted by centrifugation at 1000rpm for 10min (4ºC) 
and then broken down into single cell suspension for FACS staining. 
Conjunctival tissue (pooled- right and left eyes) from the naïve and infected mice 
at day 4 and day 10 post HSV-1 infection were dissected from the Adnexa (Figure 12) 
by using a surgical blade #11. Under the dissection microscope, loosely attached 
conjunctival tissue (includes palpebral, whole bulbar and forniceal conjunctiva) was 
separated from the sclera and eyelids by corneal scissors. The pooled conjunctival 
tissue was collected into RPMI 1640 media + Liberase TL (2.5mg/ml, Sigma-Aldrich, 
MO, USA). The samples were placed in a disruptor (1500rpm) at 37ºC for 40min, 
followed by trituration using 3ml syringe plunger and was passed through a 70µm cell 
strainer. The samples were pelleted by centrifugation at 1000rpm for 10min (4ºC) and 
then broken down into single cell suspension for FACS staining. 
Spleen samples from the naïve and infected mice were collected in ice-cold 
RPMI 1640 media supplemented with fetal bovine serum (10%) and antibiotics. 
Individual spleen tissues were triturated by using 3ml syringe plunger and was passed 
through a 70µm cell strainer. Red Blood Cells (RBCs) were lysed by using RBC lysis 
buffer (Sigma-Aldrich, MO, USA). The spleen cells were counted by using 
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hemocytometer (to plate 106 cells/well in 96 well plates for cell surface flow cytometry 
staining).    
Flow Cytometry cell surface staining 
Cell surface staining was carried out on single cell suspension processed from 
the tissue samples. Individual samples were plated in the 96 well u-bottom plates. Cells 
were washed with FACS buffer (PBS+FBS+0.1%sodium azide) followed by blocking of 
Fc receptors (CD16/32 antibody) on ice for 30min. Next, the individual samples were 
stained with fluorochrome-conjugated antibodies. The sources of antibody and dilution 
used in this study are provided in Table 1. Samples were fixed overnight with 1:1 2% 
PFA: FACS buffer and acquired the next day on LSR Fortessa flow cytometer. The data 
were analyzed using FlowJo software. 
Flow Cytometry intracellular staining 
Intracellular staining was carried out on single cell suspension processed from 
the tissue samples. Individual samples were plated in 96 well u-bottom plates. Cell 
surface staining on individual samples was carried out after blocking with Fc block 
(CD16/32 antibody) on ice for 30min. The BD Biosciences cell membrane 
permeabilizing staining buffer set (Cytofix/Cytoperm 554714, BD Biosciences, CA, USA) 
was used for intracellular pimonidazole and IGF-1R staining. The eBioscience 
transcription factor staining buffer set (005523-00, Thermofisher Scientific, MA, USA) 
was used for HIF-1α staining. The staining buffer set was used as per the 
manufacturer’s protocol. The sources of antibody and dilution used in this study are 
provided in Table 1. Samples were fixed overnight with 1:1 2% PFA: FACS buffer and 
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acquired the next day on LSR Fortessa flow cytometer. The data were analyzed using 
FlowJo software. 
RNA isolation, Quantitative Reverse Transcriptase Polymerase Chain Reaction 
(qRT-PCR), Hypoxia Signaling Pathway RT2 profiler PCR array 
 
Individual cornea samples dissected from naïve, day 5 and day 10 post HSV-1 
infection were collected into RNeasy lysis buffer (RNeasy micro kit; QIAGEN, MD, USA) 
and homogenized using a Qiagen Tissue Lyser (Qiagen, MD, USA). The total RNA was 
extracted, as per the manufacturer’s protocol (RNeasy micro kit; QIAGEN, MD, USA). 
Quantification of purified RNA was carried out using NanoDrop ND-1000 
spectrophotometer (Thermofisher Scientific, MA, USA). One microgram RNA was 
reverse transcribed using RT2 First Strand Kit (QIAGEN, MD, USA) to prepare cDNA for 
the qRT-PCR assay. The optimal cycling conditions required to run the qRT-PCR assay 
were set, starting with the hot start cycle for 10min at 95ºC, followed by the PCR 
amplification for 15s at 95ºC and 60s at 60ºC with cycle repeated 40 times. The 96-well 
Hypoxia Signaling Pathway RT2 Profiler PCR Array (Qiagen, MD, USA) was carried out 
as per the manufacturer’s protocol. The qRT-PCR assay was carried out using the CFX 
Connect Real-Time PCR Detection System (Bio-Rad, CA, USA). qRT-PCR Primers 
used in this study are provided in Table 2. The data obtained from the qRT-PCR assay 
was calculated as fold differences in gene expression after normalization with β-actin 
(housekeeping gene). The results were represented as relative gene expression by 
using the 2-ΔΔCT method of calculation [ΔΔ cycle threshold (CT) = ΔCT (experiment)-
ΔCT (control)]. 
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Lactate colorimetric assay 
L (+) Lactate concentration from the naïve (uninfected) and day 10 post HSV-1 
infection corneal lysates were measured by the lactate colorimetric assay kit (MAK064, 
Sigma Aldrich) as per the manufacturer’s protocol. Briefly, each of the corneal samples 
was collected in 150μl of lactate assay buffer. The samples were homogenized using 
handheld homogenizers (Random # 440613) and centrifuged at 13,000 x g for 10min at 
4°C to remove insoluble material. The supernatant was passed through 10KDa spin 
columns (ab93349, Abcam) to deproteinize and remove the remaining lactate 
dehydrogenase in the sample. The Elute collected from the columns (50μl) is used to 
prepare a master mix containing 50μl of the reaction mixture (2µl enzyme mix, 2µl 
lactate probe and 46µl of assay buffer). The prepared reaction mixture was then 
incubated at room temperature for 30min. Lactate standards were prepared by diluting 
100nmole/µl lactate to 1nmole/µl standard solution. Volumes of 0,2,4,6,8 and 10µl of 
1nmole/µl lactate standard were used to generate the lactate standard curve. Sample 
absorbance was measured using a colorimetric microplate reader (Molecular devices, 
spectra max plus, NH, USA) at 570nm (A570). The results were represented as 
nanograms per microliter (ng/µl). 
Viral Titration assay  
HSV-1 virus load in infected Extra-orbital lacrimal glands (EoLG) at day 5 and 
day 10 post HSV-1 infection were determined by collecting the tissues in 500µl serum-
free DMEM media and then stored in -80ºC until used. Quantification of infectious virus 
was enumerated using a standard viral plaque assay. Vero cells (CCL81, American 
Type Cell Culture, Manassas, VA;) were grown in a 12-well plate (0.2x106 cells/well). 
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The EoLG samples to be tested for viral load were thawed on ice and homogenized 
using the hand-held homogenizer (Random # 440613). The EoLG samples were 
appropriately diluted in DMEM serum free media and added to each of the wells 
containing confluently grown Vero cells. The 12 -well culture plates were incubated at 
37º C/5% CO2 for 60min. Samples were removed carefully and replaced by 1ml of 
minimal essential media/carboxymethyl cellulose overlay media. Plates were incubated 
37º C/5% CO2 for 48hrs to allow the plaque formation. The overlay media was later 
removed gently to avoid any loss of cell sheet and replaced by 1ml of glutaraldehyde 
fixative (50x diluted in 1xPBS) for 5min at room temperature. After removing the fixative, 
cells were then stained with Coomassie blue for 1hr at 37ºC. Plaques were counted 
under a bright light source to enumerate the number of plaques forming units (PFU) per 
EoLG.  
Mouse angiogenesis protein array analysis 
An array of angiogenesis-related proteins was measured in HSV-1 infected 
corneal samples from B6 and IGFBP-3-/- mice in naïve and at day 5, day 10 and day 15 
post HSV-1 infection by using Proteome Profiler Mouse Angiogenesis Array kit 
(ARY015, R&D systems, MN, USA). Cornea s dissected from the naïve and infected 
groups from B6 and IGFBP-3-/- mice were transferred to 1XPBS with protease inhibitor 
cocktail (Sigma Aldrich, MO, USA) and were stored at -80ºC. The cornea samples were 
sonicated at 50% amplitude with a cycle of 15s-pulse, followed by resting on ice for 
1min. A total of six cycles of sonication per cornea was performed. The sonicated 
samples were later centrifuged at 4ºC at 15,000 rpm for 10min. The supernatant was 
collected to estimate the protein concentration in each sample by using the BCA protein 
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assay kit (Thermo Scientific, MA, USA). Samples were pooled to obtain a minimum of 
200µg of protein for angiogenesis array analysis as per the manufacturer’s instructions. 
Positive signals on the membrane were quantified using Image Studio Lite Version 4.0.  
Enzyme-linked immunosorbent assay (ELISA) to determine the amount of Insulin-
like growth factor binding protein-3 (IGFBP-3) and Insulin-like growth factor-1 
(IGF-1)  
 
To quantitate the amount of IGFBP-3 and IGF-1 in the corneas of B6 mice, 
individual cornea sample was collected in 1XPBS with protease inhibitor cocktail (Sigma 
Aldrich, MO, USA) and stored at -80ºC. Individual samples were sonicated at 50% 
amplitude with a cycle of 15s-pulse, followed by resting on ice for 1min. A total of six 
cycles of sonication per cornea was performed. The sonicated samples were later 
centrifuged at 4ºC at 15,000 rpm for 10min. The supernatant was collected for the assay 
using mouse IGFBP-3 Duo set (DY775, R&D systems, MN, USA) and mouse IGF-1 
ELISA (22-IGF1MS-E01, ALPCO, NH, USA) and followed as per manufacturer’s 
instructions. Sample absorbance was measured using a colorimetric microplate reader 
(Molecular devices, spectra max plus, NH, USA). 
Intraperitoneal (i.p.) injection of Hypoxyprobe-1 (Pimonidazole) to detect hypoxia 
Hypoxyprobe-1(HP1-100 kit; Hypoxyprobe-1 kit, Pimonidazole Hydrochloride, 
Natural Pharmacia International Inc, MA, USA) i.p. Injection (1.2mg/20g body weight) 
was given to the naïve (uninfected) mice and at day 4, day 10 and day 15 post-infection. 
The drug was dissolved in 0.9% normal saline. Mice were euthanized ninety minutes 
after injection, to collect the enucleated eye-globes. The Individual eye-globe was 
submerged immediately into the blocks containing the OCT compound (Tissue- Tek, 
CA, USA) and was snap-frozen into liquid nitrogen. The OCT blocks were stored in -
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80ºC until used for sectioning and immunofluorescence staining with the anti-PIMO 
antibody. The source of antibody and dilution used is provided in Table 1. 
Quantification of Hypoxyprobe-1 (Pimonidazole) staining 
Immunofluorescence images stained with anti-PIMO antibody were quantified by 
measuring the area of interest showing positive staining. This was acquired by using the 
‘Threshold’ tool on a grayscale image by using the Image J software (1.4q version, open 
source software) and by setting the measurements to analyze ‘limit to threshold’ so that 
the ‘Area of fraction’ in the image is only limited to the threshold region that will be 
highlighted. Each section is set to the threshold at different areas of positively stained 
areas and was performed at least three times. The quantification of pimonidazole 
positively stained area was represented as the percentage of pimonidazole positively 
stained areas that depicts the percentage of pixels selected, by using the threshold tool 
as described previously [193,194,195]. 
In-vivo depletion of neutrophils by administration of anti-Ly6G (IA8) antibody  
Intraperitoneal (i.p.) injection of anti-Ly6G (clone IA8; BE0075-1, Bio X Cell) 
monoclonal antibody (mAb) was given to the HSV-1 infected mice at the dose of 
500µg/day/mouse- as the first injection dose. Subsequent injections were given at the 
dose of 250µg/day/mouse to the treated group of mice. The isotype-matched antibody 
was administered to a control group of infected mice. Anti-Ly6G mAb antibody injections 
were given to deplete neutrophils starting from day 7 to day 11 post HSV-1 infection for 
a total of five injections. On day 12 post-infection, mice from both the groups were given 
i.p. Injection of hypoxyprobe-1 (pimonidazole) and were euthanized ninety minutes later 
to collect corneas and spleen tissue. By flow cytometry, individual corneal samples were 
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analyzed to determine the extent of pimonidazole staining in the different subsets of 
immune cells. To confirm the in-vivo depletion of neutrophils, individual spleen samples 
were analyzed to enumerate the frequency of neutrophils (Gr1high).  
Intraperitoneal (i.p.) injection of the Acriflavine (ACF) for inhibition of hypoxia-
inducible factor-1α, 2α (HIF-1α and HIF-2α) 
 
i.p. Injection of ACF (A8126, Sigma Aldrich, MO, USA) was given to the HSV-1 
infected group of mice, and i.p. Injection of vehicle (PBS only) to the control group of 
HSV-1 infected mice. ACF i.p injection of 8mg/kg body weight in PBS- 0.2ml per mice 
were given twice a day, from day 6 to day 9 post HSV-1 infection or from day 6 to day 
11 post HSV-1 infection, for a total of 8 or 12 injections respectively. Corneal opacity 
and corneal hem-angiogenesis scores were determined in the infected corneas from 
both groups of mice by using a hand-held slit lamp microscope as described earlier in 
this section. Flow cytometry analysis of individual cornea samples from both the groups 
was performed to enumerate the frequency of immune cell subsets at day 12 post-
ocular infection. 
Topical administration of Lacritin to increase tear production in HSV-1 infected 
C57BL/6 mouse eyes 
 
Topical administration of lacritin (product received from Dr. Robert L. Mc Kown, 
Dr. Gordon W. Laurie) was given to the HSV-1 infected group of mice, four times a day 
at a dose of 4µM. Control group of HSV-1 infected mice received four times a day C-25 
(a lacritin truncation mutant). The treatment was given from day 4 through day 10 post 
HSV-1 infection. Tear levels were measured in both the treated and control group of 
mice at day 6, 8 and 10 post-ocular infections. Corneal opacity and corneal hem-
angiogenesis scores were determined in the infected corneas from both groups of mice 
by using a hand-held slit lamp microscope as described earlier in this section. Flow 
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cytometry analysis of individual extra-orbital lacrimal glands from both the groups was 
performed to detect the influx of immune cells (CD4+ CD45+) at day 10 post-ocular 
infection. 
Statistical Analysis 
Statistical analysis was carried out by using the GraphPad Prism software (San 
Diego, CA). Each of the experiments was repeated at least two times. The minimum 
number of mice used in all experiments were five (n=5). Significance (p values) in all 
experiments were calculated by using an unpaired two-tailed parametric t-test or non-
parametric Mann- Whitney U test. Statistical analysis in two independent groups was 
performed by using One-way ANOVA.  
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Figure 8: Protein Array blot is showing no IGFBP-3 expression to confirm the knock out 
phenotype in IGFBP-3
-/-
 mice. A. An Image of the protein array blot showing IGFBP-3 protein in the 
C57BL/6 mice, while no expression of IGFBP-3 was detected in the IGFBP-3-/- mice.  
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Figure 9: Phenol Red Thread Test in C57BL/6 mouse eyes. Image showing inserting 
of the cotton thread impregnated with phenol red (ZONE-QUCIK, Japan) into the lateral 
canthus of C57BL/6 mouse eyes by using the forceps. The phenol red upon contact 
with tears will change its color from yellow to red.  
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Figure 10: Dissection of Clean Cornea from C57BL/6 mouse eyes. A. Showing image of 
dissected whole eye globe placed in ice cold sterile RPMI supplemented media with 10% FBS. B. 
Showing image of dissected clean corneal cup. Dissection was performed by removing out the lens, 
attached iris, and ciliary process. Curved corneal scissors (Miltex, York, PA) was used for this 
dissection. 
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Figure 11: Dissection of Extra-orbital lacrimal gland from C57BL/6 mouse. Image of Extra-
orbital gland location in the temporal area. The circled area in the image showing the surgical 
area with the extra-orbital lacrimal gland (EoLG) located with the ducts (lacrimal ducts) 
branching off from the glands. Enlarged image of the dissected EoLG is shown in the inset.   
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Figure 12: Dissection of Adnexa from a C57BL/6 mouse. A. Showing dissected Adnexa with a whole 
eye globe and eyelid. B. Displaying an enlarged image of the Adnexa. Dissected Adnexa is used to 
further dissect the bulbar conjunctiva for FACS staining, or the whole adnexa is fixed for histology 
preparation.   
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Antibody  Clone Fluorochrome Dilution  Catalog # 
HIF-1 alpha Monoclonal Alexa 647 1:20 R&D systems, IC1935R 
HIF-2 alpha Polyclonal Unconjugated 1:100 Novus, NB100-122 
GLUT-1 EPR3915 
Monoclonal 
Alexa 488 1:50 Abcam, ab195359 
GLUT-3 Polyclonal FITC 1:200 Abcam, ab136180 
MCT-4 
(SLC16A3) 
Polyclonal  Un-conjugated  1:100 Novus, NBP1-81251 
Hypoxyprobe-1 
(Pimonidazole) 
Monoclonal FITC 1:100 Hypoxyprobe, FITC-Mab 
Donkey anti-
Rabbit 
Polyclonal Alexa 488 1:200 Molecular Probes 
A21206 
Isotype Control  Monoclonal Alexa 647 1:20 R & D systems, IC002R 
CD4 RM4-5 BV605 1:100 BD Biosciences, 563151 
 
CD11b M1/70 PerCp-Cy5.5 1:100 BD Biosciences, 550993 
CD45 30F-11 PE-Cy7 1:100 BD Biosciences, 552848 
 
Ly6G 1A8  Alexa 700 1:100 BD Biosciences, 561236 
Tuj1 1-15-79 
Monoclonal 
Un-conjugated  1:100 Covance, MRB-435P-100 
(now available from 
Biolegend) 
BrdU BU1/75 
Monoclonal 
Un-conjugated 1:100 Abcam, ab6326 
K10 
 
EP1607-IHCY 
Monoclonal  
 
Unconjugated 1:200 Abcam, ab76318 
K12 SC-17101/L-15 
Polyclonal 
Un-conjugated  1:100 Santa Cruz 
Biotechnologies,  
sc-17101 
K1 EPR17870 
Monoclonal 
 
Unconjugated 1:200 Abcam, ab185629 
PAX-6 Poly19013 Un-conjugated  1:150 Biolegend, PRB-278P 
IGF-1R (pY1131) 
K74-218 
Alexa 647 1:10 BD Biosciences, 558588 
Table1: List of Antibodies used for Immunofluorescence and Flow cytometry 
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Table2: List of Qiagen Primers used for qRT-PCR assay 
 
Catalog #  Gene Symbol              Description Ref Seq Accession # 
PPM03503F Hk2 Hexokinase 2  NM_013820.3 
PPM36694A Pfkp Phosphofructokinase, platelet NM_019703.4 
PPM05505C Pfkfb3 6-Phosphofructo-2-
kinase/fructose-2, 6-
biphosphatase 3 
NM_133232.3 
PPM04168A Slc2a1 Solute carrier family 2 
(facilitated glucose transporter), 
member 1 
NM_011400.3 
PPM04164A Slc2a3 Solute carrier family 2 
(facilitated glucose transporter), 
member 3 
NM_011401.4 
PPM27328A Slc16a3 Solute carrier family 16 
(monocarboxylic acid 
transporters), member 3 
NM_030696.3 
PPM28207F Pdk1 Pyruvate dehydrogenase 
kinase, isoenzyme 1 
NM_172665.5 
PPM29621B Cs Citrate synthase NM_026444.3 
PPM34700A Idh2 Isocitrate dehydrogenase 
2(NADP)+, mitochondrial 
NM_173011.2 
PPM05102A G6pdx Glucose-6-Phosphate 
dehydrogenase X-linked 
NM_008062.2 
PPM82289A Pgls 6-Phosphogluconolactonase NM_001294269.1 
PPM35183A Pgd Phosphogluconate 
dehydrogenase  
NM_001081274.1 
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CHAPTER 1: DEVELOPMENT OF INFLAMMATORY HYPOXIA AND   
PREVALENCE OF GLYCOLYTIC METABOLISM IN PROGRESSING 
HERPES STROMAL KERATITIS LESIONS 
 
Abstract 
Herpes Stromal keratitis (HSK) is a chronic immuno-inflammatory condition in 
cornea caused by recurrent herpes simplex virus-1 (HSV-1) infection. One of the well-
known causes of the development of hypoxia is chronic inflammation. Here, our study 
was focused on understanding the three key aspects of hypoxia, namely, (i) 
development of hypoxia in HSV-1 infected mouse cornea, (ii) identification of hypoxia-
associated glycolytic gene expression in HSV-1 infected mouse cornea, and (iii) the 
results of blocking hypoxia-inducible factor (HIF) dimerization on the pathogenesis of 
HSK. The results from this study showed the development of hypoxia associated with 
an increased level of glycolytic gene expression, an elevated level of lactate 
concentration and an increased level of neutrophils influx during clinical disease onset 
of HSK. However, in-vivo administration of anti-Ly6G antibody not only depleted 
neutrophils but also reduced the development of hypoxia that was detected by anti-
pimonidazole staining in the HSV-1 infected corneas. Nuclear stabilization of HIF-1α 
and HIF-2α was observed in the infiltrating immune cells and corneal epithelium 
respectively, in the HSV-1 infected cornea. Intriguingly, in-vivo administration of 
acriflavine inhibited nuclear stabilization of both, HIF-1α and HIF-2α during clinical 
disease onset of HSK. 
Additionally, acriflavine treatment also resulted in the reduced corneal hem-
angiogenesis with yet, an increased corneal opacity in HSV-1 infected corneas. The 
Immune cell influx upon acriflavine treatment increased neutrophil influx and in contrast, 
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a decrease in an influx of CD4 T cells and non-granulocytic myeloid cells. Overall, this 
study sheds light into the key factors involved in the development of inflammatory 
hypoxia and the expression of hypoxia-associated genes during the disease 
progression of HSK.  
Introduction 
Hypoxia is the most common phenomenon that occurs in tissues with 
inflammation [197]. The major event that occurs during hypoxia is the nuclear 
stabilization of HIF. The transcription factor, HIF remains inactive during abundant 
oxygen supply in the cells but gets activated in hypoxic conditions (depleted oxygen 
supply in the cells) [197]. The HIF isoforms, namely, HIF-1α and the HIF-2α. The 
isoforms get complexed as a heterodimer with the constitutively expressed isoform, 
HIF-1β [197]. The heterodimer translocates into the nucleus and promotes the 
transcription of a battery of genes that play a role in cell survival, cell differentiation, 
angiogenesis, and glucose metabolism [198,199]. 
HSK is a chronic inflammatory condition that develops in response to HSV-1 
infection in the cornea. As described earlier, HSK in a mouse model is broadly classified 
into pre-clinical and clinical disease phase [29]. During the pre-clinical disease phase, 
infiltrating innate immune cells with inflammatory monocytes and the NK cells and the 
type 1 interferon signaling events are involved in the process of viral replication 
[200,201]. However, viral clearance occurs at 6-day post-infection. During the clinical 
disease phase, the influx of leukocytes occurs, especially the T-cells in the corneal 
stroma. The neutrophil influx has been studied as the most prominent innate immune 
cell type during both, the pre-clinical and the clinical disease phase of HSK [30,202]. 
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Development of corneal hem- and lymph-angiogenesis, opacity and scarring that affects 
the clear vision and visual acuity are the consequences of the increased neutrophil 
influx in HSV-1 infected cornea [203,204]. It has been previously studied that the influx 
of neutrophils into mucosal tissue can re-model the development of inflammatory 
hypoxia [205,206]. Therefore, the focus of the current study was to investigate the 
development of hypoxia and hypoxia-associated gene expression during the 
progression of HSK disease.  
Results 
Development of inflammatory hypoxia in HSV-1 infected cornea 
HSV-1 infected corneas with inflamed lesions are known to become hypoxic 
[206,197]. During the clinical onset of HSK disease at day 7 post-infection, a massive 
influx of neutrophils is observed in the mouse model with HSV-1 infection in cornea 
[202]. To investigate the development of hypoxia, a chemical hypoxia marker namely, 
pimonidazole (2-nitroimidazole) was used to detect hypoxic regions in-vivo. 
Pimonidazole undergoes a cascade of chemical reactions and gets reductively activated 
in cells with hypoxia. Pimonidazole forms stable adducts by binding to the thiol groups 
in amino acids, peptides, and proteins [194,207]. These adducts can be imaged in-vivo 
by staining the tissue sample with FITC conjugated anti-pimo antibody. Notably, 
pimonidazole is not active within apoptotic and necrotic regions but specifically indicates 
hypoxic regions in the tissue [207]. HSV-1 infected mice were injected with 
pimonidazole drug intraperitoneally (i.p.) both at pre-clinical (day 4 post-infection) and at 
clinical disease phase of HSK (day 10 and 15 post-infection) as described in Materials 
and Methods. Our results showed faint staining of pimonidazole at day 4 post-infection 
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in contrast to an intense pimonidazole staining at day -10, and -15 post-infection in 
HSV-1 infected cornea (Figure 13 A). The controls used for pimonidazole staining were 
the naïve (uninfected control), day 10 post infected cornea with no pimonidazole drug 
injection and, the isotype control. As expected, all the controls showed no positive 
staining of pimonidazole. Next, we showed a progressive increase in the influx of the 
neutrophils in HSV-1 infected corneas at the clinical disease onset of HSK (Figure 13 
B). Interestingly, these results correlated with the magnitude of the pimonidazole 
staining. Additionally, quantification of pimonidazole staining was carried out that 
showed a significant increase in the pimonidazole stained hypoxic regions in the severe 
HSK compared to the mild HSK diseased corneas (Figure 13 C).  
Furthermore, to determine the contribution of neutrophils influx to the 
development of hypoxia in HSV-1 infected cornea, the depletion of neutrophils was 
carried out using the anti-Ly6G (IA8 clone) monoclonal antibody (mAb). The HSV-1 
infected mice were injected i.p. with anti-Ly6G mAb from day 7 through day 11 post-
infection as described in materials and methods. Our results confirmed the depletion of 
neutrophils by detecting the reduced frequency of Gr1 high cells (Figure 14 A) in the 
spleen of HSV-1 infected mice at day 12 post-infection. In correlation to the depletion of 
neutrophils, a significant decrease in the magnitude of the pimonidazole staining was 
observed in HSV-1 infected corneas (Figure 14 B). Recent reports have demonstrated 
the pimonidazole staining and its quantification on immune cells by using flow cytometry 
[208]. In our study, HSV-1 infected corneas, from the mice treated with anti-Ly6G mAb 
showed a significant decrease in the pimonidazole staining on non-leukocytes and 
granulocytes by using flow cytometry. On the other hand, no significant decrease in 
60 
 
 
 
pimonidazole staining was noted on the CD4 T cells (Figure 14 C). Overall our results 
corroborate the involvement of neutrophil influx to be the cause for the development of 
hypoxia in HSV-1 infected corneas with progressing HSK lesions.  
Increased mRNA levels of hypoxia-associated genes in HSK developing corneas 
Recent reports have indicated the importance of hypoxia in altering the gene 
expression profile, such as regulating cellular metabolism in the inflamed tissue [199]. 
Therefore, we hypothesized that the development of hypoxia in HSV-1 infected cornea 
is not a bystander event. The genes involved in hypoxia-associated signaling was 
detected was using the Hypoxia Signaling Pathway RT2 Profiler PCR Array on naïve, 
day-5, -10 post-infection cornea samples. Increased expression of genes encoding 
lactate transporter, glucose transporters, and glycolytic enzymes were detected in HSV-
1 infected corneas at day-10 post-infection (Figure 15). The qRT-PCR assay was 
performed to corroborate the results obtained from the PCR array. Our data showed a 
significant increase in the mRNA levels of the enzymes involved in glycolysis namely, 
Hk2 (Hexokinase-2), Pfkp (phosphofructokinase platelet), Pfkfb3 (6-phosphofructo-2-
kinase/fructose-2,6-biphosphatase 3) with an average of 3.49, 6.06 and, 7.1-fold 
increase respectively (Figure 16 A). Additionally, an increase in mRNA levels of glucose 
transporters namely, Slc2a1(Glut-1; 4.0-fold increase), Slc2a3 (Glut-3; 33.25-fold 
increase) and, Slc16a3 (Mct-4; 22.5-fold increase) was determined in HSV-1 infected 
corneas at day 10 post-infection with progressing HSK lesions (Figure 16 B). Apart from 
glycolysis, mRNA levels of genes contributing the other oxygen-dependent metabolic 
pathways were explored such as the Pentose Phosphate Pathway (PPP), and 
Tricarboxylic Acid Cycle (TCA) in HSV-1 infected corneas. 
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Interestingly, our results showed no significant increase in the genes involved in 
the mRNA levels of genes involved in regulating the oxidative phase of PPP namely, 
G6pd (glucose-6-phosphate dehydrogenase), Pgls (6-phosphogluconolactonase), Pgd 
(phosphogluconate dehydrogenase) (Figure 16 D). However, a decrease in the mRNA 
level of a gene involved in the TCA cycle namely, Pdk1 (pyruvate dehydrogenase 
kinase-1; an average of 40% decrease) was determined (Figure 16 C).  PDK1 
phosphorylation of PDH enzyme leads to deactivation of the enzyme activity in 
converting pyruvate to acetyl CoA. The acetyl CoA entering the TCA cycle is then 
converted to citrate by citrate synthase. Therefore, from our results, we further 
hypothesized that a decrease in the mRNA levels of Pdk1 would likely influence 
increased enzyme activity of PDH in HSV-1 infected corneas. Intriguingly, our results 
showed a significant increase in the mRNA levels of Idh2 (isocitrate dehydrogenase-2, 
mitochondrial), with an average of 25% reduction in Cs (citrate synthase) in HSK 
developing corneas compared to the control (naïve corneas) (Figure 16 C). Altogether, 
the results obtained from the gene expression profile suggests that glycolysis is not the 
exclusive metabolic pathway, but also TCA cycle may likely play a trivial role in HSV-1 
infected corneas during the clinical onset of the HSK disease.   
As aforementioned, our results showed a dramatic increase in the mRNA levels 
of glucose transporters (Glut-1, Glut-3) and the lactate transporter (Mct-4) in HSV-1 
infected corneas (Figure 16 B). We were further interested in studying the localization 
pattern in the frozen sections of the naïve and HSV-1 infected corneas (day-10 post 
infection) by employing immunofluorescence and confocal imaging. GLUTs and MCTs 
are the cell membrane-associated proteins with its prime function being glucose import 
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and lactate export respectively [209,210]. Our results showed a faint membrane staining 
of GLUT-1 only in the basal layer of the naïve corneal epithelium, while in day 10 post-
infection cornea intense staining of GLUT-1 was observed in the basal and wing cell 
layer of the corneal epithelium (Figure 17 A). Surprisingly, GLUT-1 staining was not 
observed in the corneal stroma, which was massively infiltrated with neutrophils and 
CD4 T cells during HSV-1 infection. 
On the other hand, GLUT-3 staining was very clearly observed in the corneal 
stroma (Figure 17 A), indicating its importance as an essential glucose transporter in the 
corneal stromal cells of HSV-1 infected cornea. Our results as shown previously (Figure 
16 B), a significant increase in the mRNA levels of MCT-4 was observed (average of 
33.25±9.82-fold increase) in HSV-1 infected cornea. In support with this, MCT-4 also 
showed an intense membrane staining in the epithelial and stromal layer of the cornea 
(Figure 17 A). Additionally, flow cytometry results also showed a significant increase in 
the expression of MCT-4 protein on the neutrophils than the CD4 T cells in HSV-1 
infected corneas (Figure 17 B). MCT-4 isoform is well known to execute lactate export 
and is reported to be highly expressed in hypoxic tissues with increased glycolysis. 
Lactate is the metabolic end-product of glycolysis that is exported or imported by 
various isoforms of MCTs [210,209]. Therefore, understanding the importance of MCT-4 
in exporting the intracellular lactate, we determined the lactate levels in the naïve vs. 
HSV-1 infected corneas (Figure 17 C). Our data showed high levels of L-lactate in day 
10- post-infection corneas compared to the uninfected corneas. Altogether, our data 
support the prevalence of glycolytic metabolism in HSV-1 infected corneas with 
progressing HSK lesions.  
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Stabilization of HIF-1α and HIF-2α in HSV-1 infected corneas 
Nuclear localization of the HIF isoforms (HIF-1α and HIF-2α) is the hallmark of 
hypoxia [211]. Therefore, we ascertained the nuclear localization of HIF-1α and HIF-2α 
in HSV-1 infected corneas by employing confocal imaging and flow cytometry 
respectively. Nuclear localization of HIF-2α was distinct in the corneal epithelium of the 
infected corneas at day 10 post-infection (Figure 18). On the contrary, no nuclear 
localization of HIF-2α was observed in the naïve or the corneas at day 4 post-infection 
(Figure 18). 
HIF-1α is well known to regulate the immune cell function [212,213,214]. During 
the clinical onset of HSK disease, corneal stroma is heavily infiltrated with CD4 T cells 
and neutrophils. Hence, we carried out intracellular flow cytometry analysis (as 
described in materials and methods) to determine the HIF-1α stabilization in infiltrating 
immune cells in HSV-1 infected corneas. Our data showed increased HIF-1α expression 
in the leukocytes than the non-leukocytes in the HSV-1 infected corneas during the 
clinical disease period (Figure 19 B). Interestingly, differential levels of HIF-1α nuclear 
localization were detected in the order of myeloid cells > CD4 T cells > neutrophils 
(Figure 19 B). Naïve B6 corneas only showed minimal levels of HIF-1α in the resident 
leukocytic cell populations (Figure 19 A). Overall, these results demonstrated the 
nuclear colocalization of HIF-1α/ HIF-2α showing a pattern of differential levels of its 
expression in specific cell types in HSV-1 infected cornea during the clinical disease 
period.  
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Acriflavine treatment aggravated corneal opacity, but reduced hem-angiogenesis 
in HSV-1 infected cornea 
As aforementioned, our results demonstrated the stabilization of HIF-1α and HIF-
2α in immune cells and corneal epithelium respectively, in HSV-1 infected corneas. 
Therefore, we selected the Acriflavine (ACF) drug to inhibit HIF signaling via direct 
binding to the PAS domain of HIF-1α and HIF-2α. This results in the blocking of HIF 
dimerization with HIF-1β causing inhibition of HIF transcription activity [215]. Systemic 
administration of ACF was given to HSV-1 infected mice as described in materials and 
methods. The effect of the drug treatment was determined by scoring corneal opacity 
and corneal angiogenesis in both the control and treated group at day 10 post-infection. 
Unexpectedly, our results showed a significant increase in the corneal opacity scores 
(Figure 20 A), while a significant decrease in angiogenesis scores was observed in the 
ACF treated group of HSV-1 infected mice (Figure 20 C). Additionally, an increased 
incidence of eyes with an opacity score of ≥3.0 was observed in ACF treated a group of 
mice (Figure 20 B). In ACF treated group of mice, a significant decrease in the mRNA 
levels of Pfkfb3 was observed in the infected corneas compared to the vehicle-treated 
group of HSV-1 infected mice (Figure 20 D). Intriguingly, our results showed a 
significant decrease in the mRNA levels of Pfkfb3 in correlation to a significant decrease 
in angiogenesis scores in the ACF treated group of infected mice. In conclusion, our 
data suggested that ACF treatment in HSV-1 infected mice are efficient in reducing the 
corneal angiogenesis alone, but not the corneal opacity.   
To further determine the potency of ACF treatment in inhibiting the nuclear 
localization of HIF-1α and HIF-2α in a non-immune and immune cell population, we 
performed confocal imaging, and intracellular flow cytometry analysis on cornea 
65 
 
 
 
samples from both groups (ACF and vehicle-treated) of HSV-1 infected mice. Our 
results from flow cytometry analysis showed a significant decrease in the stabilization of 
HIF-1α in the neutrophils and CD4 T cells in ACF treated group when compared to the 
vehicle-treated group of mice at day 12 post-infection (Figure 21 A). Our results from 
confocal images showed no stabilization of HIF-2α in the corneal epithelium of ACF 
treated group at day 12 post-infection (Figure 21 B) 
To study the immune influx in ACF treated a group of HSV-1 infected mice, the 
corneas from both groups of HSV-1 infected mice were processed for flow cytometry 
cell surface staining. Our results showed a decreased frequency of non-granulocytic 
myeloid cells and CD4 T cells while an increased frequency of neutrophil influx was 
observed in ACF treated a group of infected mice at day 12 post-infection (Figure 22) 
Overall, these results highlight the efficacy of ACF treatment in modifying the 
stabilization of HIF in immune and non-immune cell population and their role in 
modulating the leukocyte subsets in HSV-1 infected corneas at the clinical disease 
phase. 
Discussion 
Hypoxia has been well studied in association with inflammation in tissues [197]. 
The oxygen demand in the inflamed tissue is high due to the massive influx of 
metabolically active neutrophils. This is one of the likely causes for the development of 
hypoxia [216]. The process of neutrophil migration in the inflamed tissue requires an 
abundant amount of energy [216, 217]. Remarkably, in the mouse model of inflamed 
bowel disease, neutrophils are reported to shape the development of hypoxia. 
Neutrophils in inflamed tissue carry out a mechanism of ‘respiratory burst’ executed by 
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NADPH oxidase (NOX) activity. During this process, oxygen consumption is high and 
therefore leads to the oxygen depletion in the local area. 
Consequently, this causes inflammatory hypoxia [205]. Neutrophils play a crucial 
role in HSK development. Reports have indicated a positive correlation between the 
disease severity and increased influx of neutrophils in HSV-1 infected cornea [30]. In 
support, we proposed a model illustrating the development of inflammatory hypoxia in 
HSV-1 infected cornea. The newly formed blood vessels in the HSV-1 infected cornea 
will supply molecular oxygen, while infiltrating neutrophils may likely cause the oxygen 
depletion via NADPH oxidase activity causing hypoxia (Figure 23).   
Hypoxia has been well reported to influence glucose metabolism due to the 
increased energy demand in the inflamed tissue that harbors metabolizing active cells 
[199]. A significant increase in the mRNA levels of glycolytic genes in HSV-1 infected 
corneas was detected. The process of glycolysis is commenced by the uptake of 
glucose which is carried out by the membrane-bound glucose transporters (GLUTs). 
[218]. Among the various types of GLUTs, GLUT-1 has shown to be vital for CD4 
function [219]. Recent reports have suggested that GLUT-1 is essential for CD4 T cells 
in HSV-1 infected mice since the inhibition of glucose uptake reduced the HSK disease 
severity [220]. Notably, our results showed membrane-bound GLUT-1 staining only in 
the corneal epithelial cells but not in the corneal stroma which is heavily infiltrated with 
CD4 T cells and neutrophils during the clinical disease of HSK. To our surprise, 
prominent GLUT-3 staining was observed in the corneal stroma of HSV-1 infected mice. 
Reports have indicated that GLUT-3 has a higher affinity for glucose than GLUT-1 [221]. 
Hence, our results discern the functionality of GLUTs in HSK cornea suggesting a 
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crucial role of GLUT-3 in mediating glycolysis. Glycolytic cycle culminates with lactate 
as its end product especially during hypoxia [222,223]. The lactate formed in the cytosol 
is transported out of the cell via lactate transporter namely, monocarboxylate 
transporters (MCTs). MCTs are present in different isoforms, among which MCT-4 is 
highly upregulated in hypoxia [210]. A significant increase in the mRNA levels of the 
MCT-4 gene, in correlation to the increased levels of lactate in HSV-1, infected corneas 
was observed . This suggests, MCT-4 to be a designated exporter of lactate in the 
corneas with HSK lesions. Lactate is a metabolic waste from glycolysis that is exported 
out of the cell via MCT-4 and imported via MCT-1 as a metabolic fuel by cells 
undergoing mitochondria respiration [224]. Our data showed an increased mRNA level 
of MCT-1 gene in HSV-1 infected cornea (data not shown) as depicted in our proposed 
model (Figure 23), HSV-1 infected corneas may probably have pockets of oxygenated 
and hypoxic regions. In oxygenated regions mitochondrial respiration (tricarboxylic acid 
cycle- TCA) predominates by conversion of pyruvate into acetyl CoA. At this point, we 
infer from our results that lactate is a metabolic byproduct of glycolysis which serves as 
an auxiliary metabolic fuel to promote mitochondrial respiration and survive through 
hypoxia in HSK lesions. In support, our results also showed a significant increase in the 
mRNA levels of Pdk1 that indicates an increased generation of acetyl CoA followed by 
its entry into the TCA cycle in HSV-1 infected corneas. ‘Reductive carboxylation’ is 
another way responsible for generating acetyl CoA derived from glutamine. It is known 
that under a hypoxic condition or defective mitochondrial respiration, isocitrate 
dehydrogenase-2 promotes glutamine-derived citrate synthesis. Citrate later gets 
converted into acetyl CoA, thereby increasing the pool of acetyl CoA that may likely 
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enter the fatty acid metabolism or continue through the TCA cycle [225,226]. 
Interestingly, our results show increased mRNA levels of the Idh2 gene, that is probably 
executing the process of reductive carboxylation.  
Stabilization (nuclear localization) of HIF-1α/ HIF-2α) is the hallmark of hypoxia. 
The HIF isoform gets heterodimerized with HIF-1β and later gets translocated into the 
nucleus to initiate the transcription of an array of genes involved in angiogenesis, 
cellular metabolism, and apoptosis, etc. HIF-1α/ HIF-2α is known to have distinct 
functions. HIF-1α is known to regulate glycolysis and promote expression of genes 
encoding glucose/lactate transporters and glycolytic enzymes. While, HIF-2α may have 
an indirect role in initiating glycolysis via c-Myc or related factors [227]. Therefore, this 
indicates HIF-1α to possess a principal role in glycolytic metabolism [199,212]. Our 
study shows the stabilization of both, HIF-1α/ HIF-2α, which implies that both isoforms 
have a significant role in influencing mRNA levels of glycolytic genes in the corneas with 
HSK lesions. Apart from its role in regulating cellular metabolism, HIF-1α is also known 
as the ‘regulator of inflammation’ [212,213]. The HIF-1α expression has been 
determined in the innate and adaptive cell population, whereas HIF-2α expression has 
been studied in various cell types including the epithelial, endothelial and immune cells 
[214,228,229,230]. Intriguingly, our study showed a differential expression of HIF-1α on 
immune cell types including the myeloid cells, neutrophils, and CD4 T cells, while HIF-
2α was exclusively detected in the corneal epithelium of HSV-1 infected mice. Hence, 
we conclude from our results that HIF plays an essential role in corneal inflammation. 
We were further interested in studying the consequences of blocking the HIF function by 
using acriflavine (ACF) in HSV-1 infected mice. ACF binds to both HIF-1α/ HIF-2α and 
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inhibits its heterodimerization with HIF-1β which leads to the blocking of HIF 
transcription activity [231,215]. We expected the blocking of HIF transcriptional activity 
by ACF to alleviate the HSK disease severity. ACF action has been widely studied in 
tumor models to reduce angiogenesis [215]. As expected, our results showed a 
significant decrease in angiogenesis in the ACF treated group compared to the control 
group of HSV-1 infected mice. Interestingly, these results correlated with the significant 
reduction in the mRNA levels of the Pfkb3 gene (encoding glycolytic enzyme). Pfkb3 is 
known to be HIF dependent and involved in promoting pathological angiogenesis since 
its inhibition reduced the extent of the angiogenesis [232]. 
On the other hand, our results showed that ACF treatment aggravated the 
corneal opacity. This was an unexpected result. Moreover, ACF treatment also showed 
a significant increase in the influx of neutrophils in the corneas with HSK lesions. 
Studies from HIF blocking have reported increasing the ROS levels in tumor models 
[233]. ACF treatment may increase ROS levels due to an increased influx of neutrophils 
in the corneas with HSK lesions. Hence, we concluded that ACF as a sole treatment is 
not efficacious in alleviating the HSK disease severity.  
In summary, our research demonstrates the development of inflammatory 
hypoxia, correlating with the nuclear localization of HIF isoforms, and the prevalence of 
glycolytic metabolism in corneas with HSK lesions. Additionally, our data indicate that 
blocking HIF with ACF alone may not be potent in reducing HSK disease severity. 
Overall, this study provides novel insights to promote the advancement of therapeutic 
targets in targeting both, the blocking of HIF and inhibiting corneal inflammation. 
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Figure 13: Development of inflammatory hypoxia corelates with influx of neutrophils in the 
HSV-1 infected corneas.  
A. Representative immunofluorescence and confocal images showing pimonidazole (hpi) staining 
in uninfected (naive) cornea and HSV-1 infected corneas at 4-, 10-, and 15-, post-infection. 
Prominent pimonidazole adduct staining (in green) is detected in infected corneas during clinical 
disease period (10-day through 15-day post-infection). DAPI nuclear stain is shown in blue. FITC-
conjugated mouse IgG isotype control did not show hpi staining in infected cornea (Control 1). 
Similarly, the HSK cornea from a mouse that did not receive pimonidazole injection, does not show 
specific pimonidazole adduct staining in the cornea when stained with FITC conjugated anti-
pimonidazole antibody (Control 2). The images shown were acquired with 40x objective, except the 
control slides which were acquired with a 10x objective. DAPI nuclear staining in blue and 
pimonidazole adduct staining (in green B. Representative FACS plots denote an increased 
frequency of neutrophils (Ly6G+F4/80-) in HSV-1 infected corneas during the progression of clinical 
disease at day 10 and day 15 post-infection. The progression of clinical disease was also 
associated with a decrease in the frequency of macrophages (Ly6G-F4/80+) in infected corneas. 
The frequency of neutrophils and macrophages was obtained from CD45+ leukocytes in infected 
corneas. C. Scatter plot showing the quantification of pimonidazole staining in naïve and infected 
corneas with mild and severe HSK at 10-day post-infection. This depicts the magnitude of hypoxic 
regions (n=3 naïve corneas, n=8 mild HSK corneas, n=9 severe HSK corneas). Data derived is 
shown from two similar experiments. p values were calculated using non-parametric Mann-Whitney 
U test **** p≤0.0001 
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Figure 14: Significant depletion of neutrophils correlated with reduced development of hypoxia in 
HSV-1 infected corneas. A. Representative FACS plots denote the frequency of CD11b+ Gr1+ 
population in the splenocytes from isotype control, and anti-Ly6G treated groups of mice on day 12 post-
infection. FACS plots were derived from live-gated cells. Scatter plots (right) denotes the frequency of 
Gr1+ cells per spleen tissue from both groups of mice (open and closed circles) on day 12 post-infection. 
Each circle represents an individual spleen tissue from HSV-1 infected mice (n=6). Figure legend 
Continues 
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Figure 14: Legend continues 
B. Representative Eye image from the control group of mice at 12-day post ocular infection and a 
corresponding corneal section showing pimonidazole staining (left). Representative Eye image from Anti-
Ly6G treated mice at 12-day post ocular infection and corresponding frozen corneal section showing 
pimonidazole staining. Bar graph (right) denoting the percentage of pimonidazole staining area (quantified 
by using Image J software) in both groups of mouse corneas at 12-day post ocular infection. 
Pimonidazole staining shown is representative of two independent experiments (n=5 corneas per group). 
DAPI nuclear staining in blue and pimonidazole adduct staining (in green). Magnification X400.  
C. Representative pseudocolor FACS plots demonstrating gating strategy to show singlets gated cell 
population using the forward scatter height vs. area. Furthermore, live gated the cells using side and 
forward scatter to distinguish three cell populations a) non-leukocytes b) Granulocytes c) CD4+ T cells. 
Representative histogram FACS plots (top to bottom) denoting analysis of each of the cell population to 
determine the mean fluorescence intensity (MFI) of pimonidazole compared to the isotype control (Black 
line) in the control group (Magenta line) vs anti-Ly6G (blue line) treated group of mouse corneas at 12-
day post ocular infection. Scatter plot/bar graph (bottom panel) denoting pimonidazole MFI in all the three 
histograms analyzed cell populations at 12-day post-ocular infection. Data derived is shown from two 
similar experiments with n=5 per group. P values were calculated using unpaired non-parametric t-test. ** 
p≤0.01.  
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Figure 15: Hypoxia Signaling Pathway RT2 Profiler Array to show elevated expression of 
glycolysis regulating genes in the corneas with HSK lesions. PCR Array of hypoxia-associated 
signaling pathway was carried out on naive, 5-day and 10-day post-infection cornea samples showed an 
elevated expression of genes encoding glycolytic enzymes, glucose transporters, and the lactate 
transporter at 10-day post-infection. 
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Figure 16: Quantitative Real-Time Polymerase Chain Reaction Assay (RT-qPCR) to show elevated expression 
of glycolytic genes in the corneas with HSK lesions. 
RT-qPCR was carried out on uninfected and HSV-1 infected individual cornea samples. Bar graphs 
document the fold change in the level of expression of (A) glycolytic enzymes (HK2, PFKP, PFKFB3), (B) 
glucose transporters (Slc2a1 and Slc2a3), and lactate transporter (Slc16a3), (C) tricarboxylic acid cycle 
genes (Pdk1, Cs, Idh2), (D) Pentose Phosphate Pathway genes (G6pd, Pgls, Pgd) in infected individual 
corneas at 10-day POI in comparison to uninfected corneas. Data shown are representative of two similar 
experiments (n=5 corneas/group). Statistical significance was calculated using parametric two-tailed 
Student’s t-test. 
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Figure 17: Prevalence of glycolytic metabolism in the HSV-1 infected corneas. A. Showing 
membrane localization of GLUT-1 (Slc2a1), GLUT-3 (Slc2a3) and MCT-4 (Slc16a3) in infected corneas 
with HSK at 10-day post infection. Naive and HSV-1 infected frozen corneal sections were stained with 
anti-GLUT-1 (Slc2a1), GLUT-3 (Slc2a3) and MCT-4 (Slc16a3) antibodies followed by incubation with 
Alexa-488 conjugated secondary antibody. Representative images document weak GLUT1 and MCT4, 
but no GLUT3 staining in the corneal epithelium of naive corneas (top row). Intense GLUT-1 staining 
was seen only in the corneal epithelium of infected eyes, whereas GLUT3 and MCT4 staining was 
evident in epithelium and stroma of infected eyes at 10-day post-infection (bottom row). Image 
magnification is at 400X. DAPI (blue, nuclear staining), GLUT-1, GLUT-3, MCT-4 (green).  B. 
Representative FACS plots denoting the frequency of CD4+ T cells (top panel), Ly6G + neutrophils 
(bottom panel) in infected corneas at 10-day post-infection. The histogram FACS plots derived from the 
gated population of CD4+ T cells and Ly6G+ neutrophils represent the expression level of MCT4 
proteins in these immune cells. Scatter plot/bar graph (on right) demonstrate significantly increased 
level of MCT-4 protein in neutrophils than CD4+T cells in infected corneas. C. Scatter plot is showing 
significantly elevated level of L-lactate at 10-day post-infection in HSV-1 infected corneas than 
uninfected corneas. Results shown are representative of three independent experiments (n=6-7 
corneas or mice per group). Statistical significance was calculated using unpaired parametric Student’s 
t-test (** p= 0.0058). 
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Figure 18: Nuclear localization of hypoxia inducible factor-2α (HIF-2α) in the corneal epithelium 
of HSV-1 infected corneas during clinical disease period. Representative immunofluorescence 
images of frozen corneal sections showing HIF-2α staining obtained from the naïve (top panel), during 
pre-clinical period (middle panel, 4-day post ocular infection) and clinical phase (bottom panel, 10-day 
post ocular infection) of HSK. The top and bottom panel from left to right, showing nuclear staining with 
DAPI (in red), HIF-2α staining (in green), and the merged images with nuclear localization of HIF-2α (in 
yellow). Arrowheads in the bottom row indicate the epithelial cells with nuclear localization of HIF-2α in 
yellow. Magnification X400. Immunofluorescence images shown are representative of five corneas at 
each time-point.  
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Figure 19: Stabilization of Hypoxia Inducible factor-1α and its differential expression on Immune 
cell subsets in HSV-1 infected corneas. A. Representative pseudo color FACS plots of naïve cornea 
denoting the gating strategy employed for CD45- leukocytes and CD45+ leukocytes. Representative 
histogram FACS plot (right) to show isotype control and the level of intracellular HIF-1α protein in CD45- 
and CD45+ populations, respectively. B. Representative pseudo color FACS plots of an infected cornea 
at day-13 post ocular infection, denoting the gating strategy employed for CD45- leukocytes and CD45+ 
leukocytes, CD4 T cells, CD11b+ Ly6G+ neutrophils and CD11b+ Ly6G- myeloid cells. Representative 
histogram FACS plot (top to bottom) to show isotype control and the level of intracellular HIF-1α protein in 
CD4 T cells, neutrophils and myeloid cells, respectively in the infected cornea. Scatter plot/bar graph in 
the top panel demonstrates the mean fluorescence intensity (MFI) of HIF-1α protein in CD45- and CD45+ 
leukocytes. Scatter plot/bar graph in the bottom panel demonstrates the MFI of HIF-1α protein in three 
different immune cell populations in individual infected corneas at day-13 post ocular infection. Data 
derived is shown from two similar experiments with n=5 per group. Statistical significance was calculated 
used unpaired non-parametric t-test and one-way ANOVA test. **** p≤0.0001. 
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Figure 20: Acriflavine treatment aggravates corneal opacity, but significantly reduces hem-
angiogenesis in corneas with Herpes Stromal Keratitis. A. Scatter plot (on the left) is showing the 
corneal opacity score of individual corneas from control and acriflavine treated groups of HSV-1 
infected mice at 10-day post-infection. B. Bar graph (right) is showing the incidence of eyes with 
opacity score >3.0 between both groups of infected mice. C. Scatter plot is showing hem-angiogenesis 
score of individual corneas from control and acriflavine treated groups of infected mice at 10-day post-
infection. D. Scatter plot/bar graph is showing the expression of Pfkfb3 gene in individual corneas from 
control and acriflavine treated groups of infected mice at 10-day post-infection. Statistical significance 
was calculated using nonparametric Mann-Whitney U test. (n=5-6 HSV-1 infected mice per group in 
each experiment). 
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Figure 21: Acriflavine treatment significantly reduces stabilization of HIF isoforms (HIF-1/2α) 
in the immune cell subsets and nonimmune cells respectively in HSV-1 infected corneas. A. 
Representative pseudo color FACS plots demonstrating gating strategy to show singlets gated cell 
population using the forward scatter height vs area. Furthermore, live gated the cells using side 
and forward scatter to distinguish CD11b+ CD45+ Ly6G-, CD11b+ CD45+ Ly6G+ and CD11b- 
CD45+ CD4+ cell populations. Representative histogram FACS plots (top to bottom) denoting 
analysis of Neutrophils (CD11b+ Ly6G+) and CD4 T cells to determine the mean fluorescence 
intensity (MFI) of HIF-1α in the vehicle (pink peak) vs acriflavine (ACF) treated (green peak) of 
mouse corneas at 12-day post ocular infection. Scatter plot/bar graph (bottom panel) denoting HIF-
1α MFI in all the two histogram analyzed cell populations at 12-day post-ocular infection. Data 
derived is shown from two similar experiments with n=5 per group. p values were calculated using 
unpaired t-test. * p<0.05. B. Representative immunofluorescence images of frozen corneal 
sections show HIF-2α staining obtained from the vehicle (top panel), ACF treated (bottom panel), 
at 12-day post ocular infection) of HSK. The top and bottom panel from left to right, show nuclear 
staining with DAPI (in red), HIF-2α staining (in green), and the merged images with nuclear 
localization of HIF-2α (in yellow). Arrowheads in the top row indicate the epithelial cells with 
nuclear localization of HIF-2α in yellow. Magnification X400. Immunofluorescence images shown 
are representative of five corneas at each time-point. Data derived is shown from two similar 
experiments with n=5 per group. p values were calculated using unpaired t-test. * p≤0.05.  
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Figure 22: Acriflavine treatment significantly reduces the influx of non-granulocytic myeloid cells 
and CD4 T cells in HSV-1 infected corneas. Representative pseudo color FACS plots demonstrating 
gating strategy to show singlets gated cell population using the forward scatter height vs area. 
Furthermore, live gated the cells using side and forward scatter to distinguish CD11b+ CD45+ Ly6G- 
(non-granulocytic myeloid cells), CD11b+ CD45+ Ly6G+ (Neutrophils) and CD11b- CD45+ CD4+ cell 
populations in vehicle vs Acriflavine (ACF) cornea treated samples. Scatter plot/bar graph (bottom 
panel) denoting percentages of all three cell populations analyzed in vehicle vs ACF treated cornea 
samples at 12-day post-ocular infection. Data derived is shown from two similar experiments with n=5 
per group. p values were calculated using unpaired t-test.* p≤0.05, **p≤0.01, ***p≤0.001.  
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Figure 23: A proposed model to demonstrate the development of inflammatory hypoxia in HSV-1 
infected corneas during the clinical disease period. This model shows the existence of both, 
oxygenated and hypoxic regions in the HSV-1 infected cornea. In the prevalence of hem-angiogenesis, 
as one of the hallmarks of HSK disease, molecular oxygen will be likely supplied by these neo-blood 
vessels formed in the HSV-1 infected cornea. However, in presence of massive influx of neutrophils, the 
molecular oxygen may reduce into reactive oxygen species (ROS). Eventually, this process can shape 
the development of inflammatory hypoxia. 
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CHAPTER 2: EVALUATION OF EXTRA-ORBITAL LACRIMAL GLAND 
AND CONJUNCTIVAL INFLAMMATION DURING HSV-1 INFECTION 
 
Abstract 
Corneal innervation, main lacrimal gland, and ocular surface components 
including cornea, conjunctiva and meibomian gland act as a ‘functional unit’ that control 
tear production via the neural reflex arc. Sensory corneal nerves are part of the neural 
reflex arc, which regulates tear fluid production from the lacrimal gland. The loss of 
sensory corneal nerves is reported in both human and mouse herpes stromal keratitis 
(HSK). Chronic inflammation of the functional unit or one of its components may lead to 
dysfunction in tear production. Our study showed a significant reduction in tear volume 
in HSV-1 infected corneas of C57BL/6 (B6) mice during the clinical disease period. In 
this study, we demonstrated that corneal HSV-1 infection in the B6 mouse model would 
cause reduced tear levels in correlation to extra-orbital lacrimal gland (EoLG) and 
conjunctival inflammation. Our study also ascertained the outcomes of decreasing tear 
levels and their effect on lacrimal gland inflammation. Our results showed a massive 
influx of CD45+ leukocytes involving CD4 and CD8 T cells and morphological changes 
in inflamed EOLG tissues on day 10 post-infection. Most notably, the existence of the 
replicating HSV-1 virus in the EoLG was detected on day 5 post-infection. Topical 
administration of lacritin in HSV-1 infected mice did increase the tear volume at day 8 
post-infection but was not able to sustain the increase in the tear volume throughout the 
HSK disease phase. However, no change was observed neither in the influx of 
leukocytes nor in the HSK disease severity (corneal opacity and hem-angiogenesis) in 
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the lacritin treated group of HSV-1 infected mice. The conjunctival tissue was also 
detected with an increased influx of leukocytes involving CD4 and CD8 T cells. 
Interestingly, our results also showed a significantly reduced number of mucin 
contributing goblet cells in the conjunctiva at day 10 post-infection, compared to the 
uninfected(naïve) conjunctiva. Of note, these results correlated with the reduced tear 
volumes in the HSV-1 infected mice at day 10 post-infection. Taken together, our study 
suggested an increased leukocytes influx in EoLG and conjunctiva. Although lacritin 
treatment alone delayed the decrease in tear volume in infected eyes, it was not 
sufficient to inhibit leukocytes influx in EoLG of the HSV-1 infected mice. Additionally, 
conjunctival tissue likely plays an important role in reducing tear volume after ocular 
HSV-1 infection.  
Introduction 
    
HSK is an immunoinflammatory condition which persists in inflamed cornea even 
after the clearance of infectious HSV-1 virus [234]. Studies from the mouse model have 
reported the role of neutrophils and T cells in the pathogenesis of HSK [30,32]. The 
hallmark of HSK in the mouse model involves the development of corneal opacity and 
angiogenesis (hem- and lymphangiogenesis) [235,236]. Our data (Figure 24) and recent 
studies in a mouse model of corneal HSV-1 infection have reported, the loss of sensory 
corneal nerves during the progression of HSK [237,80]. The afferent sensory corneal 
nerves are part of the neural reflex arc, which regulates the secretion of tear fluid on the 
ocular surface [99,238].  
The tear film is a thin transparent layer coating the surface of the eye [239]. 
There are three distinct layers in the tear film, comprising of the top lipid layer, middle 
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aqueous and the inner mucin coat. The lipid layer is released from the meibomian 
glands and harderian gland (in mice) to prevent the tear evaporation from the ocular 
surface [240]. The aqueous layer is secreted by the lacrimal gland and helps in 
providing nutrients and oxygen to the corneal tissue.  Lacrimal gland plays an important 
role in regulating the quantity and quality of tears overlying the corneal surface [99,124]. 
The goblet cells of the conjunctival epithelium secretes mucin contributing to the mucin 
layer [241]. 
Additionally, the differentiated squamous cells with microvilli and microplicae, in 
the superficial layers of the corneal epithelium, secretes glycocalyx and maintains the 
tear film integrity [239,242]. Most of the tear film constitutes of the aqueous and mucin 
layer [241]. Tear production is highly regulated by neural reflex arc, that consists of 
parasympathetic and sympathetic innervations in the lacrimal gland that is activated by 
the afferent sensory nerves in the cornea. The activation of neural reflex arc stimulates 
the release of neurotransmitters from nerves innervating lacrimal gland and helps in 
aqueous secretion onto the tear film overlying the ocular surface [243,244]. Acinar cells 
are the main secretory cells of the lacrimal gland and surrounding these cells are the 
myoepithelial cells [99]. EoLG is the prominent lacrimal gland in mice and rats [119]. 
Here, our study highlights on EoLG in the HSV-1 infected B6 mice. Overall, an intact 
tear film is required to lubricate, supply the nutrients and helps in the diffusion of 
atmospheric oxygen to the corneal epithelium. 
It is well known that reduced tear level secretion leads to the irregularity in the 
corneal surface due to the decreased lubrication of the corneal surface. Consequently, it 
elevates the risk of damage to the corneal epithelium causing ‘dry eye’ like conditions 
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[99]. This condition can be correlated to the persistent inflammatory conditions, 
subsequently leading to the destruction of the EoLG [124]. Therefore, it is essential to 
understand the histopathology of the EoLG in the B6 mice with HSV-1 infection. 
Histologically, a normal EoLG consists of lobules that have multiple acini lined by 
columnar secretory cells which play a major role in aqueous production (a prominent 
layer in the tear film) released on to the ocular surface [245]. Under pathological 
conditions EoLG is prone to undergo dysfunction with the infiltration of immune cells 
(CD45+ /CD4+T cells) [124]. This causes a significant reduction in the exocrine function 
of the EoLG resulting in decreased tear production and ocular lubrication [243]. Herein, 
our study shows that chronic immuno-inflammatory disease caused by HSV-1 infection 
in cornea will result in inflammation of the EoLG. This leads to an alteration in tear 
production which will cause a direct impact on maintaining a moist ocular surface. 
Topical administration of lacritin, an approach to increase tear secretion, transiently 
increased the tear volume in the infected eyes during the early clinical disease phase of 
HSK. Also, the treatment had a moderate, but not statistically significant, the effect in 
reducing the severity of HSK.  
Conjunctiva is a thin semitransparent mucous membrane that covers the 
posterior surface of the eyelids and further extends into the limbus of cornea [246,129]. 
Conjunctival epithelium consists of the mucin-secreting goblet cells. Parasympathetic 
and sympathetic innervation in conjunctiva is stimulated by corneal sensory nerves to 
stimulate mucin secretion from goblet cells [135]. Conjunctival goblet cells have a key 
role in mucin production, while its responses during HSV-1 ocular infection remain 
unexplored. Infiltration of innate immune cells induces inflammatory responses in the 
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conjunctiva. However, during HSV-1 infection in the cornea, there exists a paucity of 
knowledge with the occurrence of conjunctival inflammation and its contribution in 
maintaining the stable tear volume over the ocular surface. Our study suggests that 
HSV-1 infection in B6 mouse cornea during clinical disease phase of HSK induces 
conjunctival inflammation which results in the loss of goblet cells. Interestingly, reduced 
tear volume correlates with the loss of goblet cells in the conjunctiva of HSV-1 infected 
eyes. Altogether, the purpose of this study was to evaluate inflammation in extra-orbital 
lacrimal gland and conjunctiva in the HSV-1 infected B6 mice. 
Results 
Loss of corneal nerves in HSV-1 infected eyes of C57BL/6 mice 
The cornea is an avascular and highly innervated tissue. Corneal nerve damage 
associated with the loss of sensation has been reported previously in HSV-1 infected 
corneas [80]. The existence of corneal nerves plays an essential role in maintaining an 
intact ocular surface by interconnecting with the neural reflex arc [247]. The cross-talk 
between corneal nerves and the neural reflex arc is crucial in tear production [92,190]. 
Therefore, to elucidate the corneal innervation in HSV-1 infected eyes the cornea whole 
mount of the naïve and HSV-1 infected eyes were prepared for staining with the pan-
neuronal marker- anti-Tuj1 antibody, (as described in materials and methods). Several 
reports have described corneal nerve formation, its distinct network and distribution 
pattern in the normal cornea [92,80]. Our results from the montage images acquired 
from the naïve (uninfected) cornea showed an intact network of nerves distributed from 
the central cornea to the peripheral (limbus) region (Figure 24). Tuji1staining (green) 
displayed the appearance of distinct thick nerve trunks in the limbal stromal region 
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(Figure 24 A). These nerves further ramified into smaller branches as they reached the 
paracentral region of the cornea (Figure 24 B). Prominent nerve leashes (bunches) 
were identified throughout the montage image of the naïve cornea. The nerve leashes 
further merged into the central cornea with fine branches forming a ‘central swirl’ pattern 
(Figure 24 C). In contrast, the Tuj1 stained montages of HSV-1 infected cornea at day- 
10 post-infection showed loss of corneal nerves, more prominently in the central cornea 
(Figure 24 F) with the disappearance of distinct central swirl formation. Very faintly 
stained thick limbal stromal nerve trunks were observed (Figure 24 D). No nerve 
leashes in the paracentral region were observed (Figure 24 E) as compared to the 
pattern in the naïve cornea. In conclusion, HSV-1 infected cornea had no prominent 
staining of Tuj1 indicating the deinnervation or loss of corneal nerves that may likely 
pose an impact on tear production.  
Reduced volume of tears in HSV-1 infected eyes during the clinical phase of HSK  
In mouse model, HSK is divided into pre-clinical (day -0 to -7 post-infection) and 
clinical (day -7 to -18 post-infection) disease phase [31]. During the clinical phase, the 
development of corneal opacity and angiogenesis is detected [235,237]. A study from 
our lab (Figure 24) and recent studies, in a mouse model, have shown the loss of 
sensory corneal nerves during the clinical phase of HSK [237,80]. The sensory corneal 
nerves are part of the neural reflex arc, which regulates tear secretion from the lacrimal 
gland [238]. To measure the tear volume in HSV-1 infected eyes, phenol red thread 
(PRT) test was performed on infected eyes from C57BL/6 mice at different day post-
infection, as described in Materials and Methods. PRT test was also carried out on eyes 
with no ocular HSV1 infection (naïve). Representative phenol red thread images from 
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naïve and day 10 post-infection are shown with the color change (yellow to red) on the 
thread tips after the PRT (Figure 25 A).  As shown in (Figure 25 A), an average of about 
50% decrease in tear volume was measured in HSV-1 infected eyes on day 10, when 
compared with an uninfected naïve group of mice. This experiment was carried out by 
tracking the tear level in the same eye before and after corneal HSV-1 infection (Figure 
25 A). Furthermore, the eyes with severe HSK (corneal opacity ≥3.0) were noted to 
have a reduced level of tears than the eyes with mild HSK (corneal opacity ≤1.0) (Figure 
25 A) Together, our results showed a significantly reduced tear volume in infected eyes 
during the clinical phase of HSK compared to the uninfected eyes. 
Histopathology of EoLG showing atrophy of acinar cells during clinical disease 
phase of HSK 
EoLG is the main contributor to the aqueous layer, which is the most vital layer of 
the tear film [241]. Acinar cells in EoLG play a major role in tear secretion [99]. 
Therefore, impaired function in the acinar cells may cause a severe deficiency in tear 
production. A recent study has highlighted the reduced tear volume and ‘destruction’ of 
acinar cells in the EoLG of Sjorgen’s syndrome mice model [248]. Hence, we 
hypothesized that acinar cell dysfunction might likely be the primary cause for the 
reduced tear volumes in the HSV-1 infected B6 mice. To address this, histopathology in 
EoLG was evaluated by Hematoxylin and Eosin (H&E) staining. EoLG were excised 
from the naïve, at day-4 and -10 post-HSV-1 infection. The tissues were immediately 
fixed using Excalibur’s fixative solution (as described in Materials and Methods). The 
paraffin-embedded sections were later processed for H&E staining. Our results showed 
acinar cell atrophy (circled areas in Figure 25 C) that was prominently observed in the 
EoLG that is supplying tear to the eyes with severe HSK at day 10 post-infection 
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compared to the uninfected control (naïve). Indeed, the EoLG tissue at day 10 post-
infection failed to preserve the normal architecture as in control. On the other hand, the 
EoLG which is supplying tears to the eyes with mild HSK showed infiltration of fewer 
inflammatory cells in the interstitium of the EoLG (Figure 25 C). H&E staining in the 
naïve showed compactly arranged acini in the lobules. A similar observation was noted 
in the EoLG at day 4 post-infection (Figure 25 C). Eye images depicting HSK disease 
severity and phenol red thread test images are shown in the (Figure 25 C) which 
correlates to the histopathology of EoLG. Altogether, our data suggest degeneration of 
acinar cells in the EoLG, which correlates with reduced tear volume in the eyes of HSV-
1 infected mice during the clinical phase of HSK. 
Increased influx of leukocytes in EoLG of HSV-1 infected eyes during the clinical 
phase of HSK 
EoLG play an important role in regulating the quantity and quality of aqueous 
component of the tear fluid in mouse [249]. In several pathological instances, EoLG is 
excessively infiltrated with immune cells, which may cause damage to acinar cells 
resulting in an insufficient tear production [250,251]. To determine whether corneal 
HSV-1 infection promotes leukocyte influx in EoLG, HSV-1 infected C57BL/6 mice were 
euthanized on the day -4 and -10 post-infection and EoLG was collected to perform flow 
cytometry. As is shown in our results (Figure 25 B), an average of about 3-fold increase 
in the frequency and an absolute number of CD45+ cells were seen in EoLG on day-10 
in comparison to day-4 post-infection. Among CD45+ cells, more than 5-fold increase in 
the average number of CD4 and CD8 T cells was determined in EoLG on day-10 than 
day-4 post-infection. Our results showed an increased influx of T cells in EoLG of HSV-
1 infected mice during the clinical phase of HSK. 
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Detection of Replicating virus in the EoLG tissue of HSV-1 infected B6 mice 
during the pre-clinical disease phase of HSK 
The replicating HSV-1 virus exists in cornea until day 5 to day 6 post-infection, 
after which clearance of the replicating virus occurs [203]. EoLG is innervated with both 
parasympathetic and sympathetic nerves. One of the ophthalmic branches of the 
trigeminal nerve (V1) sub-branches into the lacrimal nerve that enters the lacrimal 
gland. It is noteworthy to mention that the ophthalmic branch is interconnected with the 
sensory nerves of the cornea and the lacrimal nerve in the EOLG [252]. Therefore, we 
hypothesized that the replicating HSV-1 virus during the pre-clinical phase of HSK 
disease could possibly re-route towards the V1 branch and enter EoLG via the lacrimal 
nerve. Eventually, the residing infectious virus in the EoLG can evoke inflammation and 
cause tissue damage. Our results so far have indicated excessive tissue damage with 
the significantly increased influx of leukocytes in the EoLG of HSV-1 infected mice. To 
further elucidate the existence of the infectious virus, the excised EoLG from the day 5 
and day 10 post- HSV-1 infected mice were minced in one/two small pieces and co-
cultured with the Vero cell monolayer tissue culture flask (Figure 26 A). After the 48 
hours of incubation, these Vero cell cultures were examined for phenotypic changes. 
Notably, EoLG at day 5 post-infection showed predominant changes in the phenotype of 
Vero cells which were the typical characteristics of virus infection. As shown in (Figure 
26 B) the confluent layer of Vero cells starts getting peeled off the adherent surface and 
the rounding of cells occur. In contrast, EoLG at day-10 post-infection neither showed 
any symptoms of virus infection nor depicted any of the above-mentioned phenotypic 
changes in the Vero cell monolayer (Figure 26 C). The control showed the normal and 
healthy growth of Vero cell monolayer adherent to the surface (Figure 26 D).  
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To further quantitate the viral load in EoLG of HSV-1 infected mice during the 
pre-clinical disease phase, we carried out a viral titration assay. This assay was used to 
quantify the number of plaque forming units (PFU) from the individual EoLG of 
naïve(uninfected) and HSV-1 infected mice at day-5 post-infection. A significant 
increase in the PFU at day 5-post-infection was observed compared to the naïve 
(uninfected control) (Figure 26 E). Of note, these results correlated with our previous 
result that showed phenotypic changes in the Vero cell monolayer co-cultured with day 
5 post-infection EoLG.  Altogether, our findings indicate the existence of the replicating 
virus in the EoLG of HSV-1 infected mice.  
Lacritin treatment delayed but did not prevent the reduction in tear volume nor 
reduced the severity of HSK in HSV-1 infected C57BL/6 mice  
Lacritin is a tear glycoprotein, which has been shown to increase tear production 
in aqueous-deficient dry eye disease [253]. To determine if lacritin treatment could 
increase the tear level in HSV-1 infected eyes, topical administration of lacritin and its 
truncated control peptide (C-25) was carried out on HSV-1 infected eyes, as described 
in the Materials and Methods. A brief outline of the lacritin treatment conducted is 
shown in (Figure 27 A). HSV-1 infected eyes, receiving topical lacritin treatment, 
showed a significantly higher level of tears in comparison to truncated C-25 treated 
control group of infected mice on day 8 post-infection. However, the effect of lacritin 
attenuated with the progress of time, and on day 10 post-infection no significant 
difference in the level of tears was measured between treated and control groups of 
infected mice (Figure 27 A). No significant difference in the frequency and number of 
leukocytes infiltrating EoLG of infected mice was detected on day 10 post-infection 
when compared between both groups of mice (Figure 27 B). Although a reduced 
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corneal opacity was observed in lacritin treated than control C-25 treated HSV-1 
infected eyes on day 10 post-infection, the data was not statistically significant. 
Furthermore, the lacritin treatment alone was not effective in preventing the loss of 
corneal epithelium smoothness observed in HSV-1 infected eyes during the clinical 
disease period (Figure 27 C). Together, our results showed that Lacritin, but not C-25, 
treatment effectively delayed the decrease in tear volume in infected eyes. Lacritin 
treatment given alone to HSV-1 infected eyes had a moderate, but not statistically 
significant effect on reducing the severity of HSK. 
Loss of goblet cells in the conjunctiva of HSV-1 infected eyes during the clinical 
phase of HSK 
Conjunctival epithelium has specialized cells secreting mucins namely, the goblet 
cells. Mucins are the vital component of the tear film and hence crucial in maintaining 
the tear film overlying the corneal epithelium [254]. Reports have implied that dry eye 
conditions lead to a reduced number of goblet cells in the conjunctiva of mouse models 
[255]. In the agreement, our data showed a significant reduction in the tear volume in 
the eyes of HSV-1 infected mice (Figure 28 A) that potentially may cause dry eye 
conditions. Concerning this result, it was important to evaluate the mucin-secreting 
goblet cells in the conjunctiva of the HSV-1 infected eyes. Mucin secretion in 
conjunctival goblet cells was evaluated by periodic acid-Schiff (PAS) staining. Adnexa 
was excised from the naïve and at day-4, -10 post-HSV-1 infections. The tissues were 
immediately fixed using Excalibur’s fixative solution (as described in materials and 
methods). The paraffin-embedded sections were later processed for PAS staining. Our 
results showed distinct staining of PAS+ goblet cells in the naïve and at day 4 post-
infection lined along the conjunctival epithelium (as indicated by the arrows, Figure 28 
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A) at the fornix and superior to the fornix region. On the contrary, loss of goblet cells 
was observed in the conjunctival epithelium of HSV-1 infected eyes at day 10 post-
infection. Intriguingly, the loss of goblet cells correlated with the reduced tear volumes 
corresponding to the HSK disease severity (Figure 28 A). 
To further enumerate the number of goblet cells, quantification of the goblet cells 
in the conjunctiva of naïve, at day-4, and -10 post-infection was performed using the 
Image J software. The PAS+ goblet cells were counted per microscopic field 
(0.01mm2). A significant reduction in the number of PAS+ goblet cells was observed in 
the conjunctiva at day-10 post-infection compared to the naïve or at day-4 post-infection 
(Figure 28 B). Approximately 75% of the goblet cells were lost in the conjunctiva at day-
10 post-infection.  Our results confirm the loss of goblet cells in the conjunctiva of HSV-
1 infected eyes that may cause dysfunction in the mucin secretion and in the 
maintenance of tear film integrity.  
Increased influx of leukocytes in the conjunctiva of HSV-1 infected eyes during 
the clinical phase of HSK 
As mentioned earlier, conjunctiva has a prominent role in maintaining a moist 
and lubricated ocular surface by secretion of mucins. However, during inflammation 
dysfunction in the mucin secretion may occur causing dry eye conditions and damage to 
the ocular surface. Reports have indicated an increased infiltration of T cells in the 
conjunctiva during dry eye conditions [256]. Since our results confirmed the loss of 
goblet cells, we were further interested in characterizing the influx of leukocytes in the 
conjunctiva of HSV-1 infected eyes by using flow cytometry. The excised adnexa from 
the naïve, at day -4, and -10 post-infection were collected, and bulbar conjunctiva was 
dissected. The pooled conjunctiva samples were then processed into single cell 
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suspensions and stained with cell surface antibodies as mentioned in the materials and 
methods. As is shown in our results (Figure 29), an average of about 3-fold increase in 
the frequency of CD4 T cells and an average of 1-fold increase in CD8 T cells were 
observed in the conjunctiva on day 10 in comparison to day 4 post-infection. Our results 
demonstrated an increased influx of T cells in the conjunctiva of HSV-1 infected mice 
during the clinical phase of HSK. 
Discussion 
Our findings in this study showed reduced tear levels in HSV-1 infected eyes in 
association with inflammation in EoLG and conjunctiva. The extent of inflammation 
correlated with the severity of HSK, and the reduced volume of tears in HSV-1 infected 
eyes. We also noted the atrophy of acinar cells in the EoLG of infected mice with severe 
HSK. Our approach to increasing the tear volume, while using topical lacritin treatment, 
transiently increased the tear fluid level in HSV-1 infected eyes. Also, lacritin treatment 
partially but not significantly reduced the extent of hypoxia, and the severity of HSK.  
Recent reports [237,80] and our results (Figure 24) indicated an extensive loss of 
sensory corneal nerves in HSV-1 infected eyes during the clinical phase (day 10 post-
infection) of HSK. The bulk of aqueous tear fluid production is contributed by the 
lacrimal gland and is tightly regulated by the neural reflex arc (NRA) [99]. The NRA 
includes afferent sensory corneal nerves and parasympathetic and sympathetic 
innervations of the lacrimal gland [257]. Inputs and outputs from the sensory corneal 
nerves are reported to control the tear fluid secretion from the lacrimal gland [238]. 
Since sensory corneal nerves are involved in regulating tear production from the 
lacrimal gland, their loss in HSV-1 infected eyes will likely affect reducing the tear 
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secretion from the lacrimal gland, as shown in our results. In latent stromal herpetic 
keratitis patients, the steady-state turnover of tears is also significantly reduced and is 
considered to be the outcome of impaired lacrimation [258]. In aqueous deficient dry 
eye condition, lacrimal gland (LG) inflammation is associated with the reduced aqueous 
production of tears [124]. LG inflammation may also cause the atrophy of acinar cells. 
Our results showed a massive influx of CD4 and CD8 T cells, and the atrophy of acinar 
cells in EoLG of infected mice with severe HSK. Although the cause of increased 
infiltration of leukocytes in EoLG is not clear, the loss of sensory corneal nerves in HSK 
developing eyes may play a role in lacrimal gland inflammation. Sensory corneal nerves 
regulate neurotransmitter, such as acetylcholine and norepinephrine, secretion from the 
parasympathetic and sympathetic innervations in EoLG. It is possible that degeneration 
of sensory nerves in corneas during the clinical phase of HSK may cause a decrease in 
the release of neurotransmitters from the nerves in EoLG, and this may result in an 
excessive influx of T cells in lacrimal gland [99]. Pharmacological blockade of 
acetylcholine receptor has been shown to cause inflammation and lymphocytic 
infiltration in EoLG of B6 mice [259]. Interestingly, during inflammation reports have 
suggested the occurrence of fibrosis [260]. The process of fibrosis involves a massive 
deposition of extracellular cellular matrix components. In inflamed lacrimal gland, acinar 
cells were reported to be replaced by the ‘hyaline fibrous tissue’ [261]. In Sjogren's 
syndrome, the lacrimal gland was detected with ‘intralobular fibrosis’ associated with 
increased deposition of fat [252]. Therefore, we hypothesize that EoLG in HSV-1 
infected mice with severe HSK may be undergoing the process of fibrosis in association 
with the degeneration of acinar cells. As our result showed (Figure 25 B), a distorted 
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architecture of the EoLG, likely indicates the replacement of acinar cells with massive 
deposition of fibrous tissue.  
Lacritin is a tear glycoprotein which has recently been shown to promote the 
basal tearing in normal rabbits [262]. Besides, the topical application of lacritin 
effectively increased the tear secretion in aqueous-deficient dry eye disease [253]. In 
HSV-1 infected eyes, lacritin treatment transiently increased the tear volume, but the 
effect was attenuated by day 10 post-infection. This suggests that lacritin treatment 
alone is not highly effective in controlling HSV-1 induced inflammation of the EoLG. In 
HSK, the corneal stroma is heavily infiltrated with immune cells [263], and the latter 
causes stromal inflammation. In response to chronic stromal inflammation, the corneal 
epithelial cells may adopt an aberrant cell fate [264]. Therefore, this may have an 
impact on maintaining an intact tear film. The formation of an intact tear film on the 
corneal surface is important to preserve the corneal epithelium homeostasis. Although, 
lacritin is suggested to promote the corneal epithelium homeostasis [265]. lacritin 
treatment in association with an approach to control stromal inflammation should be 
more effective in reducing the severity of HSK.  
Conjunctival goblet cell secretion is interconnected with the neural reflex arc. The 
stimulation from the reflex arc initiates goblet cells to secrete mucins which are largely 
the membrane-bound type of mucins. Muc16 is transmembrane mucin, while Muc5a/5b 
are the large secretory mucins expressed by the goblet cells in mouse conjunctiva 
[266]. Mucins in the tear film play a major role in maintaining tear film integrity and a 
lubricated ocular surface [267]. However, in dry eye syndrome, reduced mucin secretion 
has been reported in correlation to the reduced number of goblet cells [242]. Our study 
97 
 
 
 
demonstrated a loss of corneal sensory nerves followed by the reduced tear volumes in 
the HSV-1 infected eyes. In our study, most likely due to prevalent dry eye conditions, 
loss of goblet cells in the conjunctiva of HSV-1 infected eyes were observed. This 
provides us the clues on dysfunction in mucin secretion that may directly impact the 
integrity of the tear film and the ocular surface. Reports have indicated a significant loss 
of mucin-secreting goblet cells during inflammation and in aqueous-deficient dry eyes 
[268]. In mouse models, IFN-γ is known to promote loss of goblet cells [269]. Studies 
have indicated that dry eye conditions augment the expression of IFN-γ, which indeed 
causes loss of goblet cells [268]. IFN-γ is produced by CD8 T cells Th1 lymphocytes 
and other cell types [270]. Increased infiltration of T cells in the conjunctiva during dry 
eye conditions has been reported [256]. A significant increase in the influx of T cells in 
the conjunctiva of HSV-1 infected eyes was observed. Although the cause for loss of 
goblet cells is unclear in the conjunctiva of HSV-1 infected eyes, it is likely possible that 
the influx of T cells (CD4/CD8) are the culprits involved in causing degeneration of 
conjunctival goblet cells. This provokes a vicious cycle of events initiated by a dry ocular 
surface that leads to an increased influx of IFN-γ producing T lymphocytes, 
subsequently causing loss of conjunctival goblet cells. Of note, ‘Squamous metaplasia’ 
is a pathological phenomenon detected during the loss of goblet cells and impacts the 
health of ocular surface [271,272]. In the presence of dry eye conditions and existing 
chronic inflammation in the HSV-1 infected mice, squamous metaplasia may likely 
hamper the integrity of the tear film and the corneal epithelium causing loss of vision.  
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In summary, this study broadens our knowledge to further explore the cause for 
acinar cell degeneration and the loss of conjunctival goblet cells during lacrimal and 
conjunctival inflammation respectively, in HSV-1 infected mice.   
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Figure 24: Deinnervation in HSV-1 infected cornea. Representative Confocal images of Tuj-1 stained 
corneas. Corneal whole mount staining was performed for determining the existence of corneal nerves by 
using Tuj 1- neuronal marker. Montage images were acquired at 200x magnification. The enlarged 
images of each region from montage are shown in the insets respectively. In the Naïve cornea an intact 
nerve pattern was observed in the limbus showing thick limbal stromal nerve trunks (A); in the para-
central region showing nerve leashes (bunches) running in an orientation parallel to each other 
throughout the whole corneal mount (B). The nerve bunches ramified into fine branches and merged into 
the central corneal region (C) as displayed in the montages. In day 10 HSV-1 infected cornea, loss of 
corneal nerves was observed. There are was no intact distribution of nerves compared to the naïve 
cornea. Very faintly stained stromal nerve trunks were observed (D); no nerve bunches displayed in the 
para-central region (E); loss of corneal nerves in the central region (F). TUJ1 (green). 
Immunofluorescence images shown are representative of three corneas at each time point. 
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Figure 25: Significant reduction of the tear volume correlating with inflammation in Extra-orbital 
lacrimal gland in HSV-1 infected corneas during the clinical phase of HSK. A. Representative 
Images of phenol red threads used for measuring the tear volume in the eyes of naïve and at day 10 
post-infection. The color change in threads from yellow to red depicts the tear volume. Scatter plots 
designated with colored dots represent basal tear volume in the individual naïve mouse eye followed by 
day 7 and day 10 POI (post-ocular infection). Each colored dot in the scatter plot corresponds to the tear 
volume (basal, day7 and day10 POI) of individual mouse eyes. The Bar graph on the far left is showing a 
significant reduction in the measurement of the tear volume in eyes with severe HSK compared to the 
mild HSK. Figure legend continues 
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Figure 25: Legend continues 
B. Representative hematoxylin and eosin (H&E) staining in the paraffin sections of EOLG excised from 
the naïve, HSV-1 infected mice at day 4 post-infection and at day 10 post-infection with mild HSK (top) 
and severe HSK (bottom). Eye images depict the severity of corneal opacity correlating to the phenol red 
thread images with the measurement of reduced tear volume in severe HSK eyes. Circled areas in EOLG 
of infected mice with severe HSK demonstrate the atrophy of acinar cells. C. Representative FACS plots 
denote the frequency of CD45+ cells (top panel) and CD4/CD8 T cells (bottom panel) in EOLG of HSV-1 
infected mice on 4 and 10-day post-infection. Scatter plots demonstrate a significant increase in the 
frequency and an absolute number of total leukocytes (top panel) and CD4/CD8 T cells (Bottom panel) in 
EOLG of infected mice on day10 than day 4 post-infection. Results shown are representative of two 
similar experiments. (n=5 to 8 eyes per group). Statistical analysis was performed by using unpaired two-
tailed Student’s t-test and one-way ANOVA, (*p≤0.05, **p≤0.01, ****p≤0.0001, nsp>0.05). 
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Figure 26: Detection of Infectious virus in the Extra-orbital lacrimal gland of HSV-1 infected B6 
mice at the preclinical disease phase of HSK. A. Representative image of the tissue culture flask with 
Vero cell monolayer, co-cultured with excised EoLG (minced into two tiny pieces) from HSV-1 infected 
mice at day-5 or day-10 HSV-1 post-infection. B. Representative image of the monolayer layer of Vero 
cells after 48hr co-culture with EoLG tissue excised from HSV-1 infected mice at day 5 post-infection. 
Phenotypic changes (rounding off cells and peeling off the adherent surface) in the Vero cells can be 
observed prominently. Image magnification at 10x taken to view prominent changes in the Vero cells in a 
larger area of the monolayer. C. Representative image of the monolayer layer of Vero cells after 48hr co-
culture with EoLG tissue excised from HSV-1 infected mice at day 10 post-infection. No phenotypic 
changes were observed in the monolayer of Vero cells. D. Image is showing the normal Vero cell 
monolayer as a control. D. Viral titration assay was carried to quantify the number of the plaque forming 
units (PFU) from the individual EolG of naïve(uninfected) and HSV-1 infected mice at day-5 post-
infection. A significant increase in the PFU at day 5-post-infection was observed.  (n=5 for each time point 
post-infection). Statistical analysis was performed using unpaired two-tailed Student’s t-test and one-way 
ANOVA; The p values were calculated using unpaired two-tailed Student’s t-test (*p≤0.05). 
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Figure 27: Topical administration of Lacritin transiently increases the tear volume and partially 
reduces the severity of HSK in HSV-1 infected corneas. A. Schematic of topical lacritin/C-25 
treatment regimen started at day 4 through day 10 post-infection. Images of Phenol Red Thread (PRT) 
test from C-25 control and Lacritin treated group of HSV-1 infected mice. The PRT test was performed 
to test the basal tears (before HSV-1 infection) and at day -6, -8, and -10 post-infection. Scatter plots 
represents the tear volume measured in C-25 (control) and lacritin treated groups of HSV-1 infected 
mice. Significant increase in the tear volume was observed at day 8 post-infection. B. Representative 
FACS plots denote the frequency of CD45+ cells (left panel) and CD4/CD8 T cells (right panel) in 
EOLG of C-25 (top panel) and lacritin (bottom panel) at day 10 post-infection. Scatter plots show no 
significant difference in the frequency and absolute number of CD45 (top panel) and CD4/CD8 T cells 
(bottom panel) in EOLG derived from both treated groups of mice. C. Scatter plot shows the corneal 
opacity score and angiogenesis score of individual mouse eye between both groups of mice at day-6, -
10 post-infection. Scatter plot shows the corneal smoothness scores of individual mouse eye between 
both groups of mice at 6,8 and 10 –day post-infection. Data shown are representative of two 
independent experiments. (n=5 to 8 eyes per group). The p values were calculated using unpaired two-
tailed Student’s t test (*p≤0.05, nsp>0.05). 
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FIG 28: Loss of goblet cells in the conjunctiva of HSV-1 infected cornea during the clinical phase 
of HSK. A. Infected eyes with ocular adnexa were surgically excised from the naïve C57BL/6 mice and 
on day 10 post-infection. The paraffin sections of eyes with surrounding eyelids were stained with periodic 
acid Schiff's (PAS) for the identification of goblet cells. Sections were deparaffinized before staining. 
Arrows indicate the regions in the conjunctiva (superior to fornix) with PAS-stained -goblet cells in the 
naïve (uninfected), at day-4 and -10 post-infection. Eye images and the thread test corresponds to the 
respective adnexa. Bar graphs showing the quantification of goblet cells in 0.1mm2 performed using 
Image J software. B. A significant decrease was observed in the goblet cell number of the conjunctiva at 
day 10 post-infection. (n=4 to 6 eyes per group). The p values were calculated using one-way ANOVA 
(*** p≤0.001, 
ns
p>0.05).  
A 
B 
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Figure 29: Increased infiltration of leukocytes in the conjunctiva of HSV-1 infected cornea 
during clinical phase of HSK. Representative FACS plots denote the frequency of CD45+ cells (top 
panel) and CD4/CD8 T cells (bottom panel) in the conjunctiva of HSV-1 infected mice on 4 and 10-day 
post-infection. B. Scatter plots show frequency and absolute numbers of total leukocytes (top panel) 
with a significant increase in the frequency and absolute numbers of CD4/CD8 T cells (bottom panel) 
in the conjunctiva of HSV-1 infected mice on day 10 than day 4 post-infection (bottom panel). Data 
shown are representative of two independent experiments. (n=5 to 8 eyes per group). The p values 
were calculated using unpaired two-tailed Student’s t test (*** p≤0.001, *p≤0.05 , 
ns
p>0.05). 
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CHAPTER 3: MORPHOLOGICAL ALTERATIONS IN THE CORNEAL    
EPITHELIUM DURING OCULAR HSV-1 INFECTION 
Abstract 
Corneal epithelium consists of non-keratinizing stratified squamous epithelium 
which plays an essential role in maintaining a transparent cornea, thereby providing a 
clear vision. However, previous reports have shown that during HSV-1 infection 
aberrant corneal epithelial differentiation occurs, resulting in the loss of corneal 
epithelial characteristics. Here, we hypothesized that non- keratinized corneal 
epithelium acquires a keratinized ‘skin-like epithelium’ (epidermis) in HSV-1 infected 
corneas that directly hinders clear vision and leads to corneal blindness. The previous 
study reported from our laboratory suggested reduced tear volume in the HSV-1 
infected eyes of C57BL/6 (B6) mice during the clinical disease phase. The reduced tear 
volume also increases desiccation in the eyes leading to ‘dry-eye’ condition. Our study 
showed reduced smoothness in the HSV-1 infected cornea in association to positive 
Rose Bengal staining indicative of dry eye and damaged ocular surface. It is known that 
intact non- keratinized corneal epithelium plays a major role in maintaining a moist and 
conditioned ocular surface. Corneal epithelial cytokeratin-K12 is one of the key proteins 
that function to maintain epithelial integrity and homeostasis. Therefore, in this study, 
our interest was to understand the characteristic expression pattern of cytokeratins in 
the corneal epithelium of HSV-1 infected eyes. Interestingly, our results showed the 
reduced or loss of corneal epithelial specific K12 keratin expression, while the 
appearance of epidermis-specific K10 expression was observed as the disease 
progressed during the clinical phase of HSK. To our surprise, the loss of paired box 
protein (Pax-6) expression indicative of abnormal differentiation of ocular surface 
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lineage was also observed in the HSV-1 infected corneal epithelium during the clinical 
phase of HSK. Overall, this study highlights a novel finding on the trans-differentiation of 
non-keratinized corneal epithelium to the keratinized epidermis type, in association with 
the loss of Pax-6 expression during the clinical phase of HSK disease.   
Introduction  
The cornea is an avascular tissue, which will receive oxygen supply and 
nourishment from the tear film in the anterior region and aqueous humor in the posterior 
region [43,44]. One of the hallmarks of HSK disease in mouse cornea includes damage 
of corneal nerve associated with corneal epithelial defect [237]. Corneal nerve damage 
is associated with the loss of corneal nerve fibers extending from the corneal stroma 
into the epithelium [237]. Previous results from our lab also showed a similar outcome of 
loss corneal nerves at day 10 post-infection in HSV-1 infected B6 mouse cornea [Figure 
24]. The cornea is a densely innervated tissue. The abundant nerve supply with its 
density and pattern of branching is important in maintaining the corneal integrity and 
homeostasis of corneal epithelium [80]. Corneal nerves play a predominant role in tear 
production and in maintaining the corneal epithelial integrity [273]. Reduced sensory 
corneal nerves will result in the loss of sensation and a decrease in the density of 
superficial corneal epithelial cells [273]. The loss of corneal nerves will reduce the ability 
of efficiently providing oxygen to a corneal tissue that manifests in ‘dry eye’ conditions. 
The dry eye can either be due to tearing deficiency or increased tear evaporation in the 
absence of intact corneal epithelium [274]. Therefore, production of the tear film with its 
maintenance over the intact corneal epithelium is essential to keep a moist and 
conditioned ocular surface. To evaluate the corneal smoothness, HSV-1 infected eyes 
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were scored as described in Materials and Methods. A significant increase in the 
smoothness score was observed, suggesting an increased corneal surface damage 
(Figure 30 B). In clinics, Rose Bengal staining has been widely used to detect ocular 
surface damage associated with tear film breaks or with compromised tear film integrity 
[a 275]. Our results showed purple san stained areas in HSV-1 infected eyes at day 10 
post -infection but not prominent in the uninfected eyes (Figure 30 A). Rapid corneal 
epithelial cell turnover has been reported with the increased thickness in dry eyes [276]. 
The data from our study showed increased proliferation detected by BrdU 
(BromodeoxyUridine) (Figure 31 A). BrdU is a proliferation marker, which incorporates 
into replicating DNA [263]. Further, it is detected by staining with anti-BrdU antibody and 
is imaged using a confocal microscope as detailed in Materials and Methods.  
Damage or loss of corneal nerves has been reported to show reduced levels of 
tears [277], but its influence on corneal epithelial cytokeratin expression has not been 
studied. Cytokeratin expression on the corneal epithelial cells functions to maintain the 
epithelial integrity, mechanical stability through their interaction with the tight junction 
proteins [67,278]. Hence, it is important to study the expression pattern of cytokeratin in 
the corneal epithelium. In our study, we investigated the abnormalities in the corneal 
epithelial keratin (K12) expression during HSV-1 infection. Our results showed abnormal 
expression or the loss of K12 with the appearance of K10 (epidermis-specific) in the 
corneal epithelium of HSV-1 infected eyes at day 10 post-infection (Figure 32, 33). 
Studies from other groups have also shown that reduced K12 expression is detected in 
correlation to reduced Pax-6 expression [279]. Pax-6 is a transcription factor which 
plays an essential role in the development and maintenance of ocular lineage. More 
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precisely, Pax-6 is crucial in maintaining the corneal phenotype, since Pax-6+/- mice 
showed reduced expression of K12 [280]. Our results showed that, in association with 
abnormal K12 expression, loss of Pax6 expression in HSV-1 infected cornea was 
observed during the clinical phase of HSK (day 10, 16 post -infection) (Figure 34).  
Overall, based on our previous observation of reduced tear volume in HSV-1 
infected eyes, our study sheds light on alterations in the morphology of corneal 
epithelium. Mainly, the changes in the corneal epithelium as observed by the loss of 
corneal epithelial specific cytokeratin K12 and the appearance of the epidermis-specific 
K10 is a novel finding in the HSV-1 infected eyes. Intriguingly, these results 
corroborated with the loss of Pax6 in the corneal epithelium of HSV-1 infected eyes 
which is crucial in eye development. Therefore, this study emphasis on n the 
morphology and maintenance of corneal epithelial integrity which plays a major role in 
both, tear secretion and its maintenance over the corneal surface.  
Results 
Irregular corneal smoothness and damage to the ocular surface epithelium in the 
HSV-1 infected eyes  
A smooth and conditioned corneal surface is maintained in the presence of intact 
underlying corneal epithelium. Based on our previous results that showed reduced tear 
volumes, we were curious to understand the smoothness of the corneal surface in HSV-
1 infected eyes. Corneal smoothness scoring was employed to understand the extent of 
corneal surface irregularity and was evaluated as described in materials and methods. 
Briefly, corneal smoothness score wan as evaluated on a five-point scale depending on 
the distorted quarters of the reflected ring: 0- no distortion, 5- severe distortion [281]. 
The corneal smoothness for each eye in the uninfected (naïve), at day- 4, -8, and -10 
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post-infection were recorded. Representative eye images of the naïve, at day 4 and day 
10 with the reflecting ring is shown in (Figure 30 A). Our results showed a sign 
significantly increased smoothness score in the eyes during the clinical phase of HSK 
(day 10 post-infection) compared to the naïve with a score of zero (Figure 30 B). An 
average of 2-fold increase in the corneal smoothness scores was observed at day 10-
post-infection compared to the naïve (Figure 30 B).  
We were further curious to elucidate the irregularity in the corneal surface. This 
was determined by using Rose Bengal staining in the naïve and at day 4 and 10 post-
infection. Rose Bengal staining is observed in a damaged and dry corneal surface. 
Positive Rose Bengal staining indicates damage to corneal epithelium and is routinely 
used in clinics to diagnose dry eye syndrome [275]. Our results showed a prominent 
magenta/ dark pink punctate staining on the corneal surface in the eyes at day 10 post-
infection, while faint staining in day 4 post-infection eyes, compared to no staining in the 
naïve (Figure 30 A). Taken together, our data suggest the prevalence of ocular surface 
damage indicative of dry eye conditions in HSV-1 infected eyes. 
Hyperproliferation of corneal epithelium during the clinical onset of HSK  
Immunofluorescence staining for BrdU was performed as described in Materials 
and Methods to characterize the extent of proliferation in the corneal epithelium of HSV-
1 infected eyes. As a marker for proliferation, the nuclear staining of BrdU indicates 
rapidly diving cells. Based on our previous observation (Figure 31 A), we hypothesized 
that rapid corneal epithelial cell proliferation might likely be stimulated to compensate for 
the ocular surface damage. Therefore, we sought to study the magnitude of proliferation 
in the corneal epithelium of the naïve and at day 5 and 9 post-infection. The nuclear 
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staining with BrdU was prominent in the corneal epithelium as shown in the tile scan 
image (Figure 31 A) compared to the corneal epithelium at day 5 post-infection. The 
enlarged images acquired at high magnification shows intensely stained BrdU+ cells 
(Figure 31 A). No BrdU staining was detected in the naïve (uninfected control) corneal 
epithelium. 
Furthermore, the number of BrdU+ cells were quantified using Image J software. 
BrdU+ cells were counted per microscopic field (for a total of at least three different 
fields/sample) at 20x magnification. A significant increase of BrdU labeling (average of 
20 cells/microscopic field) in the basal and suprabasal layer of corneal epithelium at day 
9 post-infection was detected, compared to the day 5 post-infection which showed few 
(<10 cells/microscopic field) BrdU labeled cells at the basal layer of the corneal 
epithelium. Nearly a 2-fold increase in BrdU labeling was observed in the corneal 
epithelium at day 9 post-infection compared to day 5 post-infection. No BrdU+ cells 
were detected in the naïve corneal epithelium (Figure 31 B). Thus, we infer from our 
results that hyperproliferation is prominent due to the rapid cell turn over in the corneal 
epithelium during the clinical onset of HSK disease.  
Trans-differentiation of corneal epithelium during the clinical phase of HSK   
In support with our previous data (Figure 30) that showed ocular surface 
damage, we were further interested to study whether the corneal epithelial phenotype is 
preserved during ocular HSV-1 infection. To study the corneal epithelial integrity, we 
sought to investigate the cytokeratin expression pattern in the corneal epithelium of 
HSV-1 infected eyes (at day-4, -10, and -16 post-infection) by using 
immunofluorescence staining for K12 cytokeratin. K12 is specifically expressed on the 
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corneal epithelium. Tile scan image of the corneal section at day-post infection showed 
the loss of K12 expression, except few regions of the paracentral cornea expressed K12 
(Figure 32). In the uninfected control (Figure 32), K12 expression was observed all 
through the corneal epithelium in a uniform pattern. Since studies have shown that 
pathological conditions transform the cytokeratin expression pattern of corneal 
epithelium to ‘skin like epithelium’ [282] we further explored to identify epidermis like 
phenotype in the corneal epithelium. To do this, we carried out immunofluorescence 
staining for K10 cytokeratin in the HSV-1 infected eyes at day-4, -10, and -16 post-
infection. Surprisingly, we detected an intense expression of K10 in the corneal 
epithelium on day 10 and day 16 post-infection (Figure 33 G, H). Moderately stained 
regions of K10 expression were visible at day 4 post-infection (Figure 33 F), while no 
K10 stained regions were detected in the naïve (uninfected control) (Figure 33 E). 
Notably, a dramatic loss of K12 staining was observed at day -10, and -16 post-infect 
tion (Figure 33 C, D), while prominent staining of K12 was observed in the naïve (Figure 
33 A). Collectively, our results showed a remarkable observation of phenotypic changes 
in the corneal epithelium during HSV-1 infection. The occurrence of ‘transdifferentiation’ 
of corneal epithelium is evident from our data indicating a switch from non-keratinized to 
a ‘keratinized skin like’ epithelium during the clinical disease phase of HSK (Figure 35). 
Loss of PAX-6 expression in the corneal epithelium during the clinical phase of 
HSK 
A characteristic feature of corneal epithelium is the expression of transcription 
factor Pax-6. Expression of Pax-6 in the corneal epithelium distinguishes it from the 
epidermis and has a key role in exclusively eye development and morphogenesis [283]. 
As aforementioned our results showed trans-differentiation of corneal epithelium that 
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showed loss of K12 expression in the HSV-1 infected cornea epithelium (Figure 32). 
Expression of K12 is specific to the corneal epithelium. Therefore, to further investigate 
whether the corneal epithelial phenotype is maintained in HSV-1 infected corneas, we 
carried out immunofluorescence staining with the anti-Pax-6 antibody. The frozen 
corneal sections from the naïve (uninfected control), at day -4, and -10 post-infection 
were used for staining with an anti-Pax-6 antibody, followed by confocal image 
acquisition. Remarkably, our results showed a dramatic loss of Pax-6 in the corneal 
epithelium during the clinical disease phase of HSK (at day -10, -16 post-infection) 
(Figure 34 G-L). In contrast, a predominant distribution of positively stained Pax-6 in the 
nucleus was observed throughout the corneal epithelium in naïve and at day 4 post-
infection (Figure 34 A-F). Here in, our results confirm the loss of corneal epithelial 
identity and the loss of differentiation in the ocular surface lineage.  
Discussion 
           In this study, we investigated a novel phenomenon on alterations of the corneal 
epithelium and its trans-differentiation into ‘skin-like epithelium’ in HSV-1 infected eyes, 
which is havoc to clear vision. The results from our study show the existence of dry eye 
associated with corneal epithelial damage, K12-/K10+ expression and the loss of Pax6 
expression in the corneal epithelium of the HSV-1 infected eyes. 
The existence of a healthy, smooth and lubricated corneal surface is critical for 
the maintenance of transparent cornea to aid clear vision. An intact cornea epithelium 
not only functions as a protective barrier but also aids in tear production and its 
maintenance. Consequently, this helps in keeping the ocular surface moist and healthy. 
However, during dry eye condition, ocular surface damage has been reported [276]. Our 
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data showed the existence of corneal epithelial damage via positive staining of Rose 
bengal with reduced corneal smoothness in HSV-1 infected eyes. Rose Bengal (RB) is 
widely known to diagnose dry eye conditions in the clinics. It is known that binding of RB 
is prominent in the regions with altered mucin layer on the ocular surface or with ocular 
surface damage [284]. Moreover, our results previously (Figure 25 A) showed reduced 
tear volumes in HSV-1 infected eyes that may also influence ‘desiccating’ ocular 
surface. In the mouse model of ‘desiccating dry eye,’ increased epithelial cell 
proliferation was observed [276]. Our results showed a similar outcome with increased 
proliferation in the corneal epithelium during HSV-1 infection determined by a positive 
BrdU staining. Of note, a phenomenon of ‘hyperplasia’ may be occurring due to the 
rapid turn-over of the cells and to compensate the damage in the corneal epithelium of 
HSV-1 infected eyes. Altogether, these results indicate the occurrence of ocular surface 
damage causing ‘dry eye’ conditions. Importantly, the increase in tear osmolarity has 
been detected in dry eye diseases which eventually induces corneal epithelial damage 
[285,286]. Thus, may pose a severe impact on preserving the corneal epithelial 
integrity.  
The expression of cytokeratin is crucial in maintaining the integrity of the corneal 
epithelium [287] Hence, cytokeratin proteins have been widely used in elucidating 
epithelial phenotype and its differentiation. Corneal epithelium comprises non-
keratinized stratified squamous epithelium. Cumulative studies have reported the 
specific expression of K3 and K12 cytokeratin in the normal corneal epithelium 
[288,71,289,290]. Nevertheless, under pathological conditions non-keratinized 
epithelium transforms into a keratinized epithelium that closely matches the features of 
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skin epithelium (epidermis). The keratin expression profile determines this switch in 
keratinization in the cornea. Typically, as previously mentioned K3/K12 are the keratins 
that are specific to the corneal epithelium, which is replaced by epidermis-specific 
K1/K10 expression under pathological conditions [282]. Intriguingly, our results showed 
the loss of K12 expression concomitant to the gain of K10 expression the corneal 
epithelium at day 10 and day 16 post-HSV-1 ocular infection. This suggests an 
occurrence of transformation or trans-differentiation in the corneal epithelium during the 
clinical stage of HSK disease progression (Figure 35).  
Additionally, Pax-6 is a prominent marker of ocular surface lineage and has a 
crucial role in the maintenance, regulation, and differentiation of corneal epithelium 
[291]. Nonetheless, mouse model studies have showed that Pax6+/- mice are prone to 
have brittle corneal epithelium [292]. Cumulative evidence from the reports have 
indicated that the corneal epithelium in Pax6+/- mice displayed an improper 
differentiation and maturation of the corneal epithelium. [293,279] Intriguingly, our data 
showed a dramatic loss of Pax-6 in the corneal epithelium during the clinical disease 
phase of HSK (at day 10 and day 16 post HSV-1 ocular infection). The loss of Pax-6 is 
known to induce upregulation of epidermis-specific expression of cytokeratin (K1/K10) 
in the corneal epithelium via a ‘default differentiation pathway’ [283] Several ocular 
disease disorders such as Stevens-Johnson syndrome, Sjogren's syndrome, and dry 
eye have reported a reduced expression of Pax-6 in association to the loss of K12, 
increased K10 expression and increased proliferation in the corneal epithelium [294]. 
Moreover, Pax-6 expression is known to be interconnected with the K12 expression, 
since Pax-6 stimulated the K12 promoter action [295]. In support, our results showed 
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the loss of K12 with the emergence of K10, increased proliferation, and the loss of Pax-
6 in the corneal epithelium during the clinical disease phase of HSK. Altogether, it can 
be concluded that Pax-6 is a key player in driving the ocular surface phenotype and in 
the development of corneal epithelium. The members of Wnt pathway play an essential 
role in signaling Pax-6 and K12 expression in the normal cornea [282] Henceforth, it will 
be interesting to further explore the factors related to the loss of Pax-6 in the corneal 
epithelium of HSV-1 infected eyes.  
In conclusion, our results confirm the transformation in corneal epithelium leading 
to the loss of corneal epithelial identity. ‘Squamous metaplasia’ is a phenomenon 
characterized by an abnormal differentiation of corneal epithelium into the skin like 
epithelium [296]. It is considered as a hallmark in Sjogren’s syndrome and Stevens-
Johnson syndrome [296,297] Notably, one of the characteristic features of squamous 
metaplasia include the loss of K3/K12 and the appearance of K1/K10 in the corneal 
epithelium [271,272]. A recent study has reported the occurrence of epithelial to 
mesenchymal transition (EMT) in HSV-1 infected corneas [298]. Overall, this evidence  
supports our study to hypothesize that, the process of squamous metaplasia may likely 
be occurring in the corneal epithelium of HSV-1 infected corneas.  
Taken together, this study provides a comprehensive guide to indicate corneal 
epithelial damage and transdifferentiation in the corneal epithelium of HSV-1 infected 
eyes.  
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Figure 30: Irregular corneal smoothness and damage to the ocular surface in the HSV-1 infected 
eyes. A. The top panel shows eye images with corneal smoothness scores. From left, naïve eyes 
showing a score of 0; at day 4 post-infection showing a score of 1; at day 10 post-infection showing a 
score of 5. Corneal smoothness scores were recorded depending on the reflected ring structure on the 
corneal surface. The intact round ring structure (naïve) signifies a corneal surface, in contrast to a 
distorted ring structure that signifies a defective/irregular corneal surface (day 10 post-infection). The 
bottom panel shows eye images stained with Rose Bengal (RB) staining. From left, naïve eyes showing 
no positive staining of RB; at day 4 post-infection with faint staining of RB indicated by arrows; at day 10 
post-infection with a prominent magenta/dark pink punctate stained area indicated by arrows. B. Bar 
graphs show the corneal smoothness in the naïve, at day-4, -8, and -10 HSV-1 infected eyes. The data 
were pooled from three independent experiments with n=4-6 eyes per group/experiment. The p values 
were calculated using one-way ANOVA (** p≤0.01, 
ns
p>0.05). 
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Figure 31: Hyperproliferation of the corneal epithelium during the clinical onset of HSK. A. 
Representative immunofluorescence tile scan images of the frozen corneal sections stained with anti-
BrdU antibody in the naïve, at day -5, and -9 post-infection. Areas showing prominent BrdU staining 
(colocalized with nuclear staining) is shown in the insets at a higher magnification (x400). Tile scan 
images were acquired at x200 magnification. DAPI (red, nuclear staining), BrdU (green). B. Bar graphs 
showing the quantification of BrdU+ cells in the naïve, at day -5, and -9 post-infection. Image J software 
was used for quantification. Statistical analysis was performed by using unpaired two-tailed Student’s t-
test (** p≤0.01, *p≤0.05).  
. 
A 
B 
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Figure 32: Loss of K12 expression the corneal epithelium during the clinical disease of 
HSK. Representative immunofluorescence tile scan images shown with anti-K12 staining in the 
naïve cornea (top panel) and at day 10 post-infection (bottom panel). The naïve corneal tile scan 
image shows an intense membrane staining of K12 throughout the entire corneal epithelium. The 
insets (A,B) shows magnified images (x400 magnification) of the K12 staining. The day 10 post-
infection corneal tile scan image shows loss of K12. K12 staining is not observed throughout the 
corneal epithelium. The insets (C,D) shows magnified images showing the areas with loss of K12 
staining. Tile scan images were acquired at x200 magnification. DAPI (blue, nuclear staining), 
K12 (green). Immunofluorescence images shown are representative of three corneas at each 
time-point.  
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Figure 33: Loss of K12 expression and the gain of K10 expression in the corneal epithelium during 
the clinical disease of HSK. Representative immunofluorescence images of frozen corneal sections 
stained with K12 (A-D); K10 (E-H). K12 is a corneal epithelial specific cytokeratin that shows intense 
staining in the naïve corneal epithelium (A) and progressively disappears at day 4 (B) showing patchy 
K12 staining; at day 10 (C) shows loss of K12, only small regions in the corneal epithelium show K12 
staining; at day 16 (D) No staining or the loss of K12) detected. K10 is an epidermis (skin) specific 
cytokeratin that shows prominent K10 staining at day 10 (G) and at day 16 (H); while a patchy staining 
pattern of K10 is observed at day 4(F); No K10 staining is observed in the naïve (control, E). 
Magnification x200. DAPI blue- nucleus staining, K12- green {A-D}. DAPI red- nucleus staining, K12- 
green {E-H}. Immunofluorescence images shown are representative of three corneas at each time-point.  
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Figure 34: Loss of Pax-6 expression in the corneal epithelium during the clinical disease of HSK. 
Representative immunofluorescence images of frozen corneal sections showing Pax-6 (green) DAPI (in 
red), and the merged images with nuclear localization of Pax-6 (in yellow). Pax-6 staining in the naïve (A-
C), prominent staining in the nucleus observed as shown in the insets with the zoomed image. At day 4 
post-infection (D-F), prominent staining in the nucleus observed as shown in the insets with zoomed 
images. At day 10 post-infection (G-I), loss of Pax-6 expression observed. At day -16 post-infection (J-L), 
loss of Pax-6 observed. Magnification X400. Immunofluorescence images shown are representative of 
three corneas at each time-point.  
  
122 
 
 
 
 
 
Figure 35: A schematic representation to depict alterations of cytokeratin expression in the corneal 
epithelium during the clinical disease period.  
This diagram shows the process of trans differentiation in the corneal epithelium of HSV-1 infected eyes. 
A loss of K12 expression (corneal epithelial specific) to the gain of the epidermis (skin) specific K10 
expression is detected in the corneal epithelium of HSV-1 infected eyes during the clinical disease phase 
of HSK.  
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Figure 36: A proposed model to summarize the events of ocular surface alterations in HSV-1 
infected cornea during the clinical disease period. This model emphasis on the impact of reduced tear 
levels observed in the HSV-1 infected cornea. 
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CHAPTER 4: IGF-1 DEPENDENT MECHANISM OF IGFBP-3 IN THE 
PATHOGENESIS OF HERPES STROMAL KERATITIS 
Abstract 
Herpes Stromal Keratitis (HSK) is a chronic immunoinflammatory condition that 
develops in response to recurrent corneal infection with herpes simplex virus-1 (HSV-1) 
and is considered a major cause of infection-induced blindness in the United States. 
Clinical manifestations of HSK involve the development of angiogenesis and opacity 
into the avascular cornea. A better understanding of immunoinflammatory events that 
promote angiogenesis and opacity in infected cornea could provide novel therapeutic 
targets to treat HSK. IGFBP-3 binds to 75% of serum IGF proteins and regulates their 
bioavailability and IGF-1R signaling. The latter is known to enhance angiogenesis and 
immune cell survival and effector function. An elevated level of IGFBP-3 protein was 
detected in HSV-1 infected corneas while carrying out angiogenic protein array in 
infected corneal samples from C57BL/6 (B6) mice. To determine the role of IGFBP-3 in 
the pathogenesis of HSK, B6 and IGFBP-3-/- mice received corneal HSV-1 infection. 
Our results showed a significant increase in hem-angiogenesis and opacity scores in 
infected corneas of IGFBP-3-/- than control B6 mice. IGFBP-3 may exert its protective 
effect by sequestering IGF molecules and reducing IGF-1R mediated signaling. In 
support, our results showed increased phosphorylation of IGF-1R expressing 
leukocytes in infected corneas of IGFBP-3-/- mice. This was associated with an 
increased number of granulocytes in HSK lesions of IGFBP-3-/- than B6 mice. IGFBP-3 
is known to undergo proteolysis by matrix metalloproteinase-3 (MMP-3), releasing 
bioactive IGF molecules. Previous reports from our laboratory detected an 
enzymatically active MMP-3 (by Zymography) in B6 corneas with HSK. Together, our 
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results suggest that IGFBP-3 is likely exerting a protective effect since their absence 
causes an increase in opacity and robust hem-angiogenesis in infected corneas. 
IGFBP-3, in IGF-dependent mode, regulates the pathogenesis of HSK. 
Introduction  
IGFBP-3 is one of the six highly conserved Insulin Growth Factor (IGF)-binding 
proteins that bind to 75% of the serum IGF proteins to form complexes and regulates 
IGF-1R signaling by sequestering IGF molecule. Indeed, IGFBP-3 helps in regulating 
the bioavailability of IGF proteins and IGF-1R mediated signaling [299,300,154] IGF 
binding to IGF-1R results in phosphorylation of tyrosine residues in IGF-1Rβ and 
thereby initiates IGF-1R signaling [301,157]. IGF-1R signaling is reported to initiate 
hem- and lymphangiogenesis and promote survival of immune cells [302,303,304,305] 
IGFBP-3 also acts in IGF-independent mode, which involves cell surface binding, 
cytosolic accumulation and nuclear localization of IGFBP-3 [306]. IGF-dependent and 
independent action of IGFBP-3 is known to regulate hem-angiogenesis [307,184]. In 
this study, we investigated the contribution of IGF dependent action IGFBP-3 and its 
role in immune survival and pathogenesis of HSK in a mouse model.  
Development of hem-angiogenesis is the hallmark of HSK in HSV-1 infected 
cornea [308]. Our interest was to ascertain the levels of protein expression involved in 
regulating hem-angiogenesis in HSV-1 infected cornea. An elevated level of IGFBP-3 
protein was detected in HSV-1 infected corneas by using a membrane-based mouse 
angiogenesis array in HSV-1 infected mouse cornea (Figure 37 A). Previous studies 
have shown that IGFBP-3 can either promote or inhibit hem-angiogenesis 
[309,141,310]. Therefore, we next evaluated the role of IGFBP-3 in the pathogenesis of 
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HSK by infecting both, the B6 and IGFBP-3-/- mice with corneal HSV-1 infection. Our 
results showed a significant increase in hem-angiogenesis and opacity scores in 
infected corneas of IGFBP-3-/- than control B6 mice (Figure 40 B). As aforementioned, 
binding of IGFBP-3 to IGF likely exerts its protective effect by sequestering IGF 
molecules and by reducing IGF-1R mediated signaling. Notably, these results 
associated with an increased influx and enhanced phosphorylation of IGF-1R 
expressing leukocytes in infected corneas of IGFBP-3-/- mice (Figure 39). Apart from 
this, IGFBP-3 is also well known to undergo proteolysis during pathological conditions 
such as diabetes, arthritis, and cancer by matrix metalloproteinases (MMPs) and may 
release the bound IGF molecules. MMP-3 and MMP-9 have been reported to involve in 
the proteolysis of IGFBP-3 in inflamed tissue [167]. Intriguingly, previous data from our 
lab showed a significant increase in the enzymatically active MMP-3 and MMP-9, which 
was detected by Zymography. From this, we conclude that the active mechanism of 
IGFBP-3 might have been compromised in the presence of proteases which cleaves the 
IGFBP-3 molecule. Therefore, this results in the increased hem-angiogenesis and 
opacity scores in the corneas of HSV-1 infected IGFBP-3-/- mice. Overall, our results 
suggest that IGFBP-3, in IGF-dependent mode, regulates the pathogenesis of HSK. 
In summary, IGFBP-3 plays a defensive role by binding to IGF-1 and thereby 
inhibits IGF-1R phosphorylation that signals to promote hem-angiogenesis in HSV-1 
infected cornea. In support to this, our results have also shown a possible protective 
role of IGFBP-3 in inhibiting IGF-1R signaling (phosphorylation) and thereby, the 
development of hem-angiogenesis in HSV-1 infected cornea during the clinical onset of 
HSK disease.  
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Results 
An Increased level of IGFBP-3 protein and mRNA expression in HSV-1 infected B6 
corneas  
Development of corneal opacity and neovascularization in an avascular cornea is 
the hallmark of HSK [308]. Primarily, the objective of this study was to understand the 
underlying mechanisms involved in the pathogenesis of HSK. Hence, a membrane-
based angiogenesis array was performed (as described in materials and methods) to 
detect the level of angiogenesis-regulating proteins in the corneal lysates of uninfected 
(naïve) and at day -5, -10, and -15 post-HSV-1 infection. Interestingly, our results 
showed an increased pixel density of IGFBP-3 in HSV-1 infected corneas (Figure 37 A). 
The pixel density was determined by using the Image studio lite software. We further 
sought to confirm this result by performing ELISA and qRT-PCR assay to estimate the 
IGFBP-3 protein and mRNA levels of IGFBP-3 in HSV-1 infected corneas, respectively. 
A Significant increase in, mRNA levels of IGFBP-3 gene (Figure 37 B) and the IGFBP-3 
protein expression (Figure 37 C) and was detected in the HSV-1 infected corneas 
during the clinical disease phase of the HSK disease (day -10 and -15 post infection, 
respectively) when compared to the corneas during pre-clinical phase of HSK disease 
(day 5 post-infection).  
Furthermore, our angiogenesis protein array data (Figure 37 A) showed an 
increased level of matrix metalloproteinase-3, and -9 (MMP-3, -9) in infected corneas 
with HSK. Recently, the zymography data from our lab also confirmed the enzymatic 
activity of MMP-3 in HSK corneas (data not shown). Collectively, these results provoked 
us to focus on the role of IGFBP-3 protein in the pathogenesis of HSK and to further 
study the impact of MMP-3, -9 on IGFBP-3. 
128 
 
 
 
A significant increase in IGF-1R phosphorylation detected in total leukocytes 
present in HSK developing corneas of IGFBP3-/- than the control C57BL/6 (B6) 
mice 
 IGFBP-3 under specific conditions has been reported to either promote or inhibit 
hem-angiogenesis [309,307,184] Furthermore, IGFBP-3 is known to exert their function 
via insulin-like growth factor (IGF)-dependent and -independent mechanisms (Figure 7). 
IGF-dependent activity includes sequestration of IGF-I, and -II proteins and thereby 
regulates their bioavailability to the cell surface IGF-1 receptor (IGF-1R) [153]. IGF 
molecules bind to the IGF-receptor to mediate its autophosphorylation. Subsequently, 
downstream signaling events occur to initiate the process of hem-angiogenesis, 
immune cell survival and effector function [304,305,311] (Figure 38A). However, 
proteolysis of IGFBP-3 can induce enhanced IGF signaling, due to an increased 
IGF/IGF-R interaction [166,312]. A study from our laboratory has shown an increased 
expression of MMP-3 and its enzymatic activity detected in HSV-1 cornea. In support, 
our protein array data (Figure 37 A) also showed higher levels of MMP-3 and MMP-9 in 
HSV-1 infected corneas. Several reports have suggested that in inflamed tissue, MMPs 
are involved in the proteolysis of IGFBP-3 [168,167] Taken together, we hypothesized 
that active IGF-1R signaling might be induced due to increased expression of MMPs, 
that leads to the IGFBP-3 proteolysis in HSV-1 infected corneas.  
Concerning this, our foremost interest was to study the phosphorylated 
(activated) IGF-1R expression in the HSV-1 infected corneas of B6 mice. 
Immunofluorescence staining of the frozen corneal section showed positive staining for 
phosphorylated IGF-1R (pIGF-1R) in the HSV-1 infected B6 cornea at the clinical 
disease phase of HSK (day -10 and -17 post-infection) compared to the naïve (Figure 
38 B). IGF-1R staining was carried out in the frozen corneal section by using the anti-
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IGF-IR antibody (Table 1) that distinguishes the phosphorylated tyrosine 1161 (pY1161) 
in the IGF-1 receptor. Intense staining was detected explicitly in the corneal stroma of 
HSV-1 infected eyes at day 17 post-infection (Figure 38 B). This result suggests active 
IGF-1R signaling in the corneas of the HSV-1 infected eyes of B6 mice.  
To further quantitate the IGF-1R phosphorylation and to study the IGF dependent 
action of IGFBP-3, we opted to use IGFBP-3 -/- mice in this study. The IGFBP-3 -/-  mice 
on the B6 background [313] were provided by Dr. Steinle laboratory as mentioned in 
Materials and Methods. Quantification of IGF-1R phosphorylation was determined by 
employing flow cytometry analysis in IGFBP-3 -/- and the control B6 HSV-1 infected 
mice. Our data showed a significant increase in the frequency of CD45+ cells 
(leukocytes) and an absolute number of CD4+ T cells in IGFBP-3 -/- than the B6 mice on 
day 10 post-infection (Figure 39 A, B). Intriguingly, a significant increase in the IGF-1R 
phosphorylation at tyrosine residue 1131 (pY1131) was detected in leukocytes (CD45+ 
cells) infiltrating HSK corneas in IGFBP-3 -/- than the B6 mice on day 10 post-infection 
(Figure 39 C).  
Notably, these results suggest an increased immune cell influx and active IGF-1R 
signaling in leukocytes infiltrating IGFBP-3 -/- mice in HSK corneas. Moreover, this study 
provides us the cues on IGF dependent action of IGFBP-3 in HSV-1 infected corneas.   
Development of robust HSK disease with a significant increase in hem-
angiogenesis and corneal opacity in HSV-1 infected eyes of IGFBP3-/- than the 
control B6 mice 
Upon understanding the existence of active IGF-1R signaling in leukocytes 
infiltrating HSV-1 infected IGFBP-3 -/- mouse corneas, we were next inclined to 
determine the role of IGFBP-3 in regulating the severity of HSK. Active IGF-1R signaling 
is known to promote hem-angiogenesis and enhance inflammation [304,311,314]. 
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Therefore, we were prompted to hypothesize that, HSV-1 infected IGFBP-3 -/- mouse 
corneas may display a severe HSK disease. To test this, B6 and IGFBP-3 -/- HSV-1 
infected mouse corneal opacity, and hem-angiogenesis scores were assessed by using 
a hand-held slit lamp as described in Materials and Methods. As expected, our results 
showed a robust HSK disease in the IGFBP-3 -/- than the B6 HSV-1 infected mouse 
corneas (Figure 40 A). A significant increase in the corneal opacity and hem-
angiogenesis scores were evaluated in the HSV-1 infected corneas of IGFBP-3 -/- 
mouse corneas during the clinical disease phase of HSK (at day-10, and -12 post-
infection) (Figure 40 B). Together, these results suggest that IGFBP-3 plays an 
essential role in governing the severity of HSK.  
Discussion 
Corneal hem-angiogenesis and associated immunoinflammatory events in HSV-
1 infected cornea are the prominent features of HSK [234,108]. Hence, a better 
understanding of the molecules involved in the regulating angiogenesis, immune cell 
survival and effector function in HSK corneas is essential. Our results from the 
angiogenesis array data showed an increased expression of IGFBP-3 in HSV-1 infected 
corneas (Figure 37 A). IGFBP-3 under specific conditions has been reported to either 
promote or inhibit hem-angiogenesis [309,307,184,310]. Notably, an increased hem-
angiogenesis and massive influx of leukocytes were detected in the HSV-1 infected 
corneas of IGFBP-3 -/- than the B6 infected mice. This indicates an essential role of 
IGFBP-3 in the pathogenesis of HSK.  
Interestingly, our angiogenesis array data showed an increased expression of 
MMP-3 and -9 in HSV-1 infected corneas in B6 mice (Figure 37 A). MMP-3 is known to 
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cause proteolysis of IGFBP-3 [167,165,166]. MMP-3 and -9 are reported to trigger 
proteolysis of IGFBP-3 resulting in the in the enhancement of the IGF- mediated actions 
[166,165,167]. In the mouse model of HSK, the expression and activity of MMP-9 have 
been reported in HSV-1 infected corneas [170]. MMP-3 serves as an activator of pro-
MMP-9 and is involved in the generation of an active form of MMP-9 [171]. Thus, in 
HSK corneas, MMP-3 may regulate the effect of MMP-9 and more importantly in the 
proteolysis of IGFBP-3.   
The mechanism of action of IGFBP-3 can either be in an IGF-dependent or 
independent manner. Briefly, IGF- dependent action is executed by sequestration of 
IGF-I and II proteins and thereby modulating their bioavailability to cell-surface IGF-1 
receptor (IGF-1R). IGF-independent action involves cell surface binding of IGFBP-3 and 
its cytosolic or nuclear localization [179,153]. The aim of this study was to determine the 
IGF dependent action of IGFBP-3. Since IGF molecules get complexed with IGFBP-3, 
the proteolysis of IGFBP-3 in HSV-1 infected cornea may liberate IGF molecules. 
Subsequently, the liberated IGF molecules can bind to IGF-1R which indeed can lead to 
enhanced activation of IGF-1R signaling (autophosphorylation of IGF-1R). Our results 
showed an intense staining for phosphorylated IGF-1R (IGF-1R, Tyr1161) in HSV-1 
infected B6 corneas during the clinical disease period (day-10, -17 post -infection) 
(Figure 38).  This suggests active IGF-1R signaling, which could be due to the 
proteolysis of IGFBP-3 by enzymatically active MMP-3.  
IGF-1R signaling has been widely reported to have pleiotropic effects, which 
include enhancing cell proliferation and migration, promoting hem-angiogenesis, 
immune cell survival and its effector function [314,160,304,305]. In support, our results 
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showed enhanced IGF-1R phosphorylation in infiltrating leukocytes of HSV-1 infected 
IGFBP-3 -/- mice than the B6 mice (Figure 39). A robust development of HSK disease 
was observed with increased corneal opacity and hem-angiogenesis in the HSV-1 
infected IGFBP-3 -/- mice than the B6 mice (Figure 40). These results elucidate the 
involvement of MMP-3 in the proteolysis of IGFBP-3 which consequently leads to 
activated signaling of the IGF receptor and its adverse effect on HSK disease severity.  
To further ensure the role of IGFBP-3 in HSK pathogenesis and its IGF 
dependent mechanism, an approach to block IGF-1R phosphorylation was carried out in 
HSV-1 infected mice. PPP inhibits IGF-1R phosphorylation in a non-ATP competitive 
manner [316]. 
In this study, we deciphered the role of IGFBP-3 in HSK developing corneas that 
may provide cues for novel therapeutic targets and reduce HSK disease severity.    
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Figure 37: A. Increase in IGFBP3 protein expression in C57BL/6 mouse corneas at different time 
points post-ocular HSV-1 infection. A. Images showing angiogenesis array blots of corneal lysates 
prepared from the naïve and HSV-1 infected cornea at day 5, 10 and 15 post-ocular infections. Bar 
diagram on the right showing the quantification of dots represented as signal intensity of IGFBP3, MMP-3, 
MMP-9 and TIMP-1 using image studio lite software. MMPs -Matrix metalloproteinases, and TIMPs- 
Tissue inhibitor of Matrix Metalloproteinases. B. Scatter plot showing the relative mRNA expression of 
IGFBP3 in HSV-1 infected B6 mouse corneas at day 5 and 10 post infection (DPI). C. Bar graph showing 
the protein levels of IGFBP-3 using ELISA in HSV-1 infected B6 mouse corneas at day 5 and day 15 
post-infection.  
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FIGURE 38: Intense IGF-1R staining in HSV-1 infected C57BL/6 (B6) mouse cornea during the 
clinical disease period. A. schematic of proposed mechanism hypothesizing active IGF-1R signaling by 
binding to IGF molecule to initiate Tyr-kinase phosphorylation (pY1161). Increased IGF-1R 
phosphorylation may promote hem-lymph angiogenesis and Immune cell survival. B. From the left 
showing frozen naïve corneal tissue section of B6 mice with no prominent IGF-1R staining, on day 10 
post-infection showing prominently in the corneal epithelium and the stroma, on day 17 post-infection 
showing intense IGF-1R staining in the corneal stroma. DAPI staining nucleus in blue; pIGF-1R detecting 
phosphorylated IGF-1R (pY1161) in green. Magnification x400.  
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Figure 39: Significant increase in IGF-1R phosphorylation detected in total leukocytes in HSK 
developing corneas of IGFBP-3-/- in comparison to the C57BL/6 mice. A. Representative FACS plots 
are denoting the frequency of leukocytes in HSV-1 infected cornea from the B6 and IGFBP-3 KO mice at 
day10 post-ocular infection (POI). B. Scatter plot is showing a significant increase in the frequency of 
CD45+ cells in IGFBP-3KO mice than the B6 on day 10 POI. Bar graph is showing a significant increase 
in the absolute number of CD4+ T cells in IGFBP-3KO mice than the B6 on day 10 POI. C. Overlay 
depicts the higher levels of phosphorylated IGF-1R in infected corneas of IGFBP-3 KO compared to the 
B6 mice. The scatter plot on the right showing a significant increase in Mean fluorescence intensity (MFI) 
of the phosphorylated IGF-1R in the total leukocytes present in the infected corneas of IGFBP3-KO mice 
than the B6 on day10 POI. Results shown are representative of two similar experiments. (n=5 to 8 eyes 
per group) p values were calculated using two-tailed t-test. **p≤0.01, ***p≤0.001, ***p≤0.0001 
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Figure 40: Robust development of HSK disease in HSV-1 infected IGFBP-3-/- mice in comparison to 
the C57BL/6 mice. A. Representative eye images of B6 and IGFBP-3-/- mice showing more severe 
disease in the IGFBP-3KO mice with robust development of angiogenesis than in the B6 mice at day 10 
and 12 post-ocular HSV-1 infections (POI) during the clinical disease of HSK. B. Scatter plots showing 
corneal opacity scores and corneal angiogenesis scores at day 7, day 10 and day 12 post-HSV-1 
infection, measured using a slit lamp. Both groups of mice were infected with a low dose of virus (10 to 4 
p.f.u). Results shown are representative of two similar experiments. (n=5 to 8 eyes per group). p values 
were calculated using two-tailed t-test. **p≤0.01, ***p≤0.001.   
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Figure 41: Schematic Representation to summarize the Aims investigated in 
this study in HSV-1 infected mouse corneas. 
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Herpes stromal keratitis (HSK) is a chronic immuno-inflammatory ocular disease 
caused by Herpes simplex virus-1 (HSV-1) infection in the cornea. HSK is characterized 
by the development of corneal opacity and angiogenesis accompanied by the loss of 
corneal transparency. Despite extensive studies on inhibiting corneal angiogenesis and 
strategies to reduce HSK disease development, a key underlying mechanism to 
maintain an intact and a transparent corneal surface during HSK disease progression, 
remain obscure. Our study has addressed possible causes for the HSK disease severity 
by identifying the key factors such as the development of inflammatory hypoxia, 
reduced tear volume, Inflammation of extra-orbital lacrimal gland and the conjunctiva 
and the transdifferentiation of the corneal epithelium in the HSK developing eyes. 
Intriguingly, our study also emphasizes the protective role of IGFBP-3 in inhibiting the 
severe disease progression of HSK.   
During the pre-clinical and the clinical disease phase of HSK, the influx of 
neutrophils have been studied as the most prominent innate immune cell type. 
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Development of corneal hem- and lymph-angiogenesis, opacity and epithelial defects 
hinders the clear vision and is known to be the cause of the increased neutrophil influx 
in HSV-1 infected cornea. Previous studies have indicated that the influx of neutrophils 
into mucosal tissue can re-model the development of inflammatory hypoxia. Therefore, 
the aim of this study was to investigate the development of hypoxia and hypoxia-
associated gene expression during the progression of HSK disease. Our results showed 
an increased influx of neutrophils during the clinical disease of HSK that leads to the 
development of hypoxia, and the upregulation of hypoxia-associated genes. This study 
provided us novel insights on the prevalence of the glycolytic metabolism in the HSK 
developing eyes. Additionally, our data demonstrated that the blocking of Hypoxia-
Inducible Factor (HIF) with Acriflavine alone might not be an efficacious drug in reducing 
HSK disease severity. Overall, these results pave way for using novel therapeutic 
targets that play a dual role to block HIF and control corneal inflammation during HSK. 
Maintaining a healthy corneal epithelium, retaining a steady tear volume and its 
secretion could be the other factors that may aid in alleviating HSK disease severity. 
Mounting evidence corroborates corneal nerves as a critical factor in the maintenance 
of corneal integrity and homeostasis of the ocular surface by mediating the reflex 
actions of blinking and tearing. In support, in a mouse model during HSV-1 ocular 
infection, corneal nerve damage has been demonstrated. Hence, corneal transparency 
and clear vision are critically dependent upon the integrity of corneal tissue maintained 
by the intricate network of corneal nerves, the presence of intact corneal epithelium and 
tear film that is controlled by a cross-talk between the components of the lacrimal 
functional unit. Our study showed a reduced measurement of tear volume in the HSK 
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developing eyes correlating to the inflammation in the extra-orbital lacrimal gland 
(EoLG) and the conjunctiva. Atrophy of tear secreting acinar cells in the EoLG, the 
significant loss of goblet cells in the conjunctiva and the influx of leukocytes and CD4 T 
cells were the major events occurring during the HSV-1 infection. These events caused 
dysfunction to the lacrimal functional unit, thereby inducing severe HSK and ‘dry eye’ 
conditions. Nevertheless, topical treatment of lacritin (tear glycoprotein) delayed but did 
not prevent the reduction in tear volume nor reduced the severity of HSK.  
Existence of a healthy, smooth and lubricated corneal surface is critical for the 
maintenance of transparent cornea to aid clear vision. Corneal epithelium comprises of 
non-keratinized stratified squamous epithelium. Nevertheless, under pathological 
conditions non-keratinized epithelium transforms into a keratinized epithelium that 
closely matches the features of skin epithelium (epidermis). The keratin expression 
profile determines this switch in keratinization in the cornea. Cytokeratin-12 (K12) is one 
of the keratins specific to the corneal epithelium, which is replaced by epidermis-specific 
cytokeratin-10 (K10) expression under pathological conditions. Intriguingly, our data 
showed the loss of K12 expression with the emergence of K10 expression during the 
clinical stage of HSK disease. Our data suggested the occurrence of corneal epithelial 
transformation. Another prominent marker, PAX-6 (paired box -6 transcription factor) 
has a crucial role in the maintenance of corneal epithelial identity by regulation of its 
differentiation. Our data showed a dramatic loss of PAX-6 expression in the HSK 
developing eyes. ‘Squamous metaplasia’ is the pathological phenomenon characterized 
by abnormal differentiation of corneal epithelium into the skin like epithelium. Overall, 
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our results signified the ‘trans-differentiation of corneal epithelial cells to the skin like 
epithelium, in HSV-1 infected mouse cornea. 
Corneal hem-angiogenesis is one of the hallmarks of HSK. Hence, it is essential 
to understand better the molecules involved in regulating hem-angiogenesis, immune 
cell survival, and its effector function. Intriguingly, angiogenesis array data showed an 
increased expression of IGFBP-3 in the HSV-1 infected corneas of C57BL/6 (B6) mice. 
Therefore, we were inclined to study the role of IGFBP-3 molecule in HSV-1 infected B6 
corneas.  IGFBP-3 is one of the six highly conserved IGF-binding proteins. IGFBP-3 
binds to 75% of the serum IGF-I and IGF-II in complexes and regulates IGF-1R 
signaling by sequestering IGF molecule. IGF binding to IGF-1R results in 
phosphorylation of tyrosine residues in IGF-1Rβ chain. IGF-1R signaling that has been 
reported to promote angiogenesis (hem- and lymph-angiogenesis). Our data indicated 
severe HSK disease with robust angiogenesis in IGFBP-3-/- mice associated with a 
significant increase in IGF-1R phosphorylation in the infiltrated leukocytes. These 
results suggest the protective role of IGFBP-3 in inhibiting IGF-1R phosphorylation that 
leads to the development of severe HSK disease progression.   
Altogether, this study broadens our knowledge on understanding several 
factors involved in the alterations of the ocular surface system during the 
pathogenesis of HSK. In summary, this study highlights on five crucial factors that 
may play an essential role in reducing HSK disease pathogenesis in the cornea; 1) 
regulating the development of inflammatory hypoxia 2) maintaining of the stable tear 
volume 3) reducing the lacrimal and conjunctival inflammation 4) maintaining the 
corneal epithelial integrity 3) alleviating corneal hem-angiogenesis (Figure 42). 
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